<4D F736F F D BC95EB8F875F8BC690D18F C082D191D682A68CE3816A2E646F6378>

Size: px
Start display at page:

Download "<4D6963726F736F667420576F7264202D20323031333132323696BC95EB8F875F8BC690D18F57816995C082D191D682A68CE3816A2E646F6378>"

Transcription

1 腎 臓 透 析 医 のための 臨 床 研 究 デザイン 塾 修 了 者 による 臨 床 研 究 業 績 この 業 績 一 覧 は 塾 修 了 後 に 発 表 された 臨 床 研 究 に 関 する 原 著 論 文 学 会 抄 録 ( 基 礎 研 究 総 説 以 外 )のみを 記 載 いたしました 自 己 報 告 に 基 づいて 作 成 した 報 告 書 ですので 全 てを 網 羅 した 業 績 集 計 ではございません 同 一 の 業 績 が 複 数 の 塾 生 により 報 告 されている 場 合 集 計 では 1 編 ( 件 )としています なお 記 載 の 順 は 塾 参 加 当 時 の 名 簿 に 依 ります 業 績 集 計 英 文 原 著 論 文 331 編... p.1 和 文 原 著 論 文 国 際 学 会 発 表 国 内 学 会 発 表 102 編...p 件...p 件...p.53 受 賞 39 件...p.84 (2013 年 8 月 現 在 ) 認 定 NPO 法 人 健 康 医 療 評 価 研 究 機 構 (ihope International)

2 英 文 原 著 論 文 長 谷 川 毅 (1 期 生 ) 20. Shoji S, Murayama T, Mimura I, Wada T, Kume H, Goto A, Ohse T, Tanaka T, Inagi R, Van der Hoom, FA, Manabe I, Honma Y, Fukayama M, Sakurai T, Hasegawa T, Aburatani H, Kodama T, Nangaku M. Sperm-associated antigen 4, a novel hypoxia-inducible factor 1 target, regulates cytokinesis and its expression correlates with the prognosis of renal cell carcinoma. Am J Pathol (in press). 19. Perl J, Zhang J, Gillespie B, Wikström B, Fort J, Hasegawa T, Fuller DS, Pisoni RL, Robinson BM, Tentori F. Reduced survival and quality of life following return to dialysis after transplant failure: the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant. 2012; 27(12): Nakai S, Iseki K, Itami N, Ogata S, Kazama JJ, Kimata N, Shigematsu T, Shinoda T, Shoji T, Suzuki K, Taniguchi M, Tsuchida K, Nakamoto H, Nishi H, Hashimoto S, Hasegawa T, Hanafusa N, Hamano T, Fujii N, Masakane I, Marubayashi S, Morita O,Yamagata K, Wakai K, Wada A, Watanabe Y, Tsubakihara Y. An overview of regular dialysis treatment in Japan (as of 31 december 2010). Ther Apher Dial. 2012; 16(6): Fukagawa M, Fukuma S, Onishi Y, Yamaguchi T, Hasegawa T, Akizawa T, Kurokawa K, Fukuhara S. Prescription Patterns and Mineral Metabolism Abnormalities in the Cinacalcet Era: Results from the MBD-5D Study. Clin J Am Soc Nephrol. 2012; 7(9): Nakai S, Suzuki K, Masakane I, Wada A, Itami N, Ogata S, Kimata N, Shigematsu T, Shinoda T, Syouji T, Taniguchi M, Tsuchida K, Nakamoto H, Nishi S, Nishi H, Hashimoto S, Hasegawa T, Hanafusa N, Hamano T, Fujii N, Marubayashi S, Morita O, Yamagata K, Wakai K, Watanabe Y, Iseki K, Tsubakihara Y. Overview of regular dialysis treatment in Japan (as of 31 December 2009). Ther Apher Dial. 2012;16(1): Yokoyama Y, Sasaki S, Suzukamo Y, Yamazaki S, Takegami M, Kakudate N, Hasegawa T, Haga M, Kawaguchi T, Moriya T, Hotta O, Fukuhara S, for the Dialysis Nutrition Research Group. Interpersonal psychosocial factors associated with underreported dietary energy intake in hemodialysis patients. Journal of Renal Nutrition 2012 (in press). 14. Akizawa T, Kido R, Fukagawa M, Onishi Y, Yamaguchi T, Hasegawa T, Fukuhara S, Kurokawa K. Decreases in PTH in Japanese Hemodialysis Patients with Secondary Hyperparathyroidism: Associations with Changing Practice Patterns. Clin J Am Soc Nephrol. 2011; 6(9): Fukuhara S, Akizawa T, Fukagawa M, Onishi Y, Yamaguchi T, Hasegawa T, Kurokawa K. Mineral and bone disorders outcomes study for Japanese chronic kidney disease stage 5D patients (MBD-5D): rationale and study design. Ther Apher Dial. 2011; 15(2): Hasegawa T, Bragg-Gresham JL, Pisoni RL, Robinson BM, Fukuhara S, Akiba T, Saito A, Kurokawa K, Akizawa T. Changes in Anemia Management And Hemoglobin Levels following Revision of a Bundling Policy to Incorporate Recombinant Human Erythropoietin. Kidney Int. 2011; 79(3): Nakai S, Suzuki K, Masakane I, Wada A, Itami N, Ogata S, Kimata N, Shigematsu T, Shinoda T, Syouji T, Taniguchi M, Tsuchida K, Nakamoto H, Nishi S, Nishi H, Hashimoto 1

3 S, Hasegawa T, Hanafusa N, Hamano T, Fujii N, Marubayashi S, Morita O, Yamagata K, Wakai K, Watanabe Y, Iseki K, Tsubakihara Y. Overview of regular dialysis treatment in Japan (as of 31 December 2008). Ther Apher Dial. 2010;14(6): Hasegawa T, Koiwa F, Yamazaki S, Yoshimura A. In Reply to 'Predialytic Period and Baseline Peritoneal Membrane Status-Any Connection?'. Perit Dial Int. 2010; 30(4): Nakai S, Masakane I, Shigematsu T, Hamano T, Yamagata K,Watanabe Y, Itami N, Ogata S, Kimata N, Shinoda T, Syouji T, Suzuki K, Taniguchi M, Tsuchida K, Nakamoto H, Nishi S, Nishi H, Hashimoto S, Hasegawa T, Hanafusa N, Fujii N, Marubayashi S, Morita O,Wakai K, Wada A, Iseki K, Tsubakihara Y. An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2007). Ther Apher Dial. 2009; 13(6): Yokoyama Y, Suzukamo Y, Hotta O, Yamazaki S, Kawaguchi T, Hasegawa T, Chiba S, Moriya T, Abe E, Sasaki S, Haga M, Fukuhara S. Dialysis Staff Encouragement and fluid control adherence in patient on hemodialysis. Nephrol Nurs J. 2009;36(3): Yokoyama Y, Yamazaki S, Hasegawa T, Wakita T, Akiba T, Akizawa T, Asano Y, Saito A, Kurokawa K, Fukuhara S. Impact of early referral to nephrologist on mental health among hemodialysis patients: a Dialysis Outcomes and Practice Patterns Study (DOPPS). Nephron Clin Pract ;113(3):c191-c Hasegawa T, Bragg-Gresham JL, Yamazaki S, Fukuhara S, Akizawa T, Kleophas W, Greenwood R, Pisoni RL. Greater First-Year Survival on Hemodialysis in Facilities in Which Patients Are Provided Earlier and More Frequent Pre-Nephrology Visit. Clin J Am Soc Nephrol. 2009; 4(3): Hasegawa T, Yoshimura A, Hirose M, Komukai D, Tayama H, Watanabe S, Koiwa F, Yamazaki S, Ideura T. A Strict Low Protein Diet during the Predialysis Period Suppresses Peritoneal Permeability at the Induction of Peritoneal Dialysis. Perit. Dial. Int. 2009; 29(3): Koiwa F, Hasegawa T, Tanaka R, Kakuta T. Indication and efficacy of PEIT in the management of secondary hyperparathyroidism. NDT Plus. 2008; 1(Supplement 3): iii14-iii Akizawa T, Pisoni RL, Akiba T, Saito A, Fukuhara S, Asano Y, Hasegawa T, Port FK, Kurokawa K. Japanese Hemodialysis Anemia Management Practices and Outcomes ( ): Results from the DOPPS. Nephrol Dial Transplant. 2008; 23(11): Ethier J, Mendelssohn D, Elder S, Hasegawa T, Akizawa T, Akiba T, Canaud B, Pisoni RL. Vascular Access Use and Outcomes: An International Perspective From the Dialysis and Outcomes Practice Patterns Study. Nephrol Dial Transplant. 2008; 23(10): Hasegawa T, Elder SJ, Bragg-Gresham JL, Pisoni RL, Yamazaki S, Akizawa T, Jadoul M, Hugh RC, Port FK, Fukuhara S. Consistent Aspirin Use Associated with Improved Arteriovenous Fistula Survival among Incident Hemodialysis Patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol. 2008; 3(5):

4 柴 垣 有 吾 (1 期 生 ) 26. Hanafusa N, Hamasaki Y, Kawarasaki H, Kido R, Shibagaki Y, Ishikawa A, Enomoto. Y, Fujita T, Noiri E, Nangaku M. The effect of different apheresis modalities on coagulation factor XIII level during antibody removal in ABO-blood type incompatible living related renal transplantation. Transfus Apher Sci Jul 1. doi:pii: S (13) /j.transci [Epub ahead of print] PubMed PMID: Fukagawa M, Yokoyama K, Koiwa F, Taniguchi M, Shoji T, Kazama JJ, Komaba H, Ando R, Kakuta T, Fujii H, Nakayama M, Shibagaki Y, Fukumoto S, Fujii N, Hattori M, Ashida A, Iseki K, Shigematsu T, Tsukamoto Y, Tsubakihara Y, Tomo T, Hirakata H, Akizawa T; CKD-MBD Guideline Working Group; Japanese Society for Dialysis Therapy. Clinical practice guideline for the management of chronic kidney disease-mineral and bone disorder. Ther Apher Dial Jun;17(3): doi: / PubMed PMID: Hiraki K, Yasuda T, Hotta C, Izawa KP, Morio Y, Watanabe S, Sakurada T, Shibagaki Y, Kimura K. Decreased physical function in pre-dialysis patients with chronic kidney disease. Clin Exp Nephrol Apr;17(2): doi: /s Epub 2012 Aug 22. PubMed PMID: Nishi H, Shibagaki Y, Kido R, Tamura S, Nangaku M, Sugawara Y, Fujita T. Chronic renal outcome after living donor liver transplantation. Clin Transplant Jan-Feb;27(1):90-7. doi: /ctr Epub 2012 Sep 2. PubMed PMID: Oishi D, Koitabashi K, Hiraki K, Imai N, Sakurada T, Konno Y, Shibagaki Y, Yasuda T, Kimura K. Physical activity is associated with serum albumin in peritoneal dialysis patients. Adv Perit Dial. 2012;28: PubMed PMID: Kawarazaki H, Shibagaki Y, Kido R, Nakajima I, Fuchinoue S, Ando K, Fujita T, Fukagawa M, Teraoka S, Fukumoto S. Kidney transplantation restored uncoupled bone turnover in end-stage renal disease. Clin Nephrol Jul;78(1):10-6. PubMed PMID: Sakurada T, Kojima S, Oishi D, Koitabashi K, Miyamoto M, Shirai S, Shibagaki Y, Yasuda T, Sato T, Kimura K. Prothrombin fragment (F1 + 2) in effluent is a useful marker for peritoneal permeability in peritoneal dialysis patients using neutral dialysate. Adv Perit Dial. 2011;27:2-5. PubMed PMID: Kawarazaki H, Shibagaki Y, Fukumoto S, Kido R, Ando K, Nakajima I, Fuchinoue S, Fujita T, Fukagawa M, Teraoka S. Natural history of mineral and bone disorders after living-donor kidney transplantation: a one-year prospective observational study. Ther Apher Dial Oct;15(5): doi: /j x. Epub 2011 May 25. PubMed PMID: Yazawa M, Kido R, Shibagaki Y, Yasuda T, Nakazawa R, Sasaki H, Sato Y, Chikaraishi T, Kimura K. Kidney function, albuminuria and cardiovascular risk factors in post-operative living kidney donors: a single-center, cross-sectional study. Clin Exp Nephrol Aug;15(4): doi: /s Epub 2011 Apr 19. PubMed PMID: Kawarazaki H, Shibagaki Y, Fukumoto S, Kido R, Nakajima I, Fuchinoue S, Fujita T, Fukagawa M, Teraoka S. The relative role of fibroblast growth factor 23 and parathyroid hormone in predicting future hypophosphatemia and hypercalcemia after living donor 3

5 kidney transplantation: a 1-year prospective observational study. Nephrol Dial Transplant Aug;26(8): doi: /ndt/gfq777. Epub 2011 Feb 8. PubMed PMID: Nakaya I, Namikoshi T, Tsuruta Y, Nakata T, Shibagaki Y, Onishi Y, Fukuhara S; School of Designing Clinical Study for Nephrologists and Dialysis Physicians. Management of asymptomatic hyperuricaemia in patients with chronic kidney disease by Japanese nephrologists: a questionnaire survey. Nephrology (Carlton) Jul;16(5): doi: /j x. PubMed PMID: Tsuruoka K, Yasuda T, Koitabashi K, Yazawa M, Shimazaki M, Sakurada T, Shirai S, Shibagaki Y, Kimura K, Tsujimoto F. Evaluation of renal microcirculation by contrast-enhanced ultrasound with Sonazoid as a contrast agent. Int Heart J May;51(3): PubMed PMID: Nishi H, Shibagaki Y, Hirano K, Akahane M, Kido R, Nangaku M, Kaname S, Sasahira N, Isayama H, Tada M, Tsukamoto R, Ohtomo K, Omata M, Fujita T. Laboratory and imaging features of kidney involvement in autoimmune pancreatitis: incidence, correlation, and steroid therapy response. Clin Nephrol Apr;73(4): PubMed PMID: Kido R, Shibagaki Y, Iwadoh K, Nakajima I, Fuchinoue S, Fujita T, Teraoka S. Persistent glomerular hematuria in living kidney donors confers a risk of progressive kidney disease in donors after heminephrectomy. Am J Transplant Jul;10(7): doi: /j x. Epub 2010 Mar 26. PubMed PMID: Kido R, Shibagaki Y, Iwadoh K, Nakajima I, Fuchinoue S, Fujita T, Teraoka S. Very low but stable glomerular filtration rate after living kidney donation: is the concept of "chronic kidney disease" applicable to kidney donors? Clin Exp Nephrol Aug;14(4): doi: /s y. Epub 2010 Mar 26. PubMed PMID: Kido R, Shibagaki Y, Iwadoh K, Nakajima I, Fuchinoue S, Fujita T, Teraoka S. How do living kidney donors develop end-stage renal disease? Am J Transplant Nov;9(11): doi: /j x. Epub 2009 Aug 14. PubMed PMID: Kusumi E, Kami M, Hara S, Hoshino J, Yamaguchi Y, Murashige N, Kishi Y, Shibagaki Y, Shibata T, Matsumura T, Yuji K, Masuoka K, Wake A, Miyakoshi S, Taniguchi S. Postmortem examination of the kidney in allogeneic hematopoietic stem cell transplantation recipients: possible involvement of graft-versus-host disease. Int J Hematol Mar;87(2): doi: /s Epub 2008 Feb 9. PubMed PMID: Kawarazaki H, Shibagaki Y, Shimizu H, Kawarazaki W, Ito N, Ishikawa A, Fukumoto S, Fujita T. Persistent high level of fibroblast growth factor 23 as a cause of post-renal transplant hypophosphatemia.clin Exp Nephrol. 2007;11: Shibagaki Y, Matsumoto M, Kokame K, Ohba S, Miyata T, Fujimura Y, Fujita T.: Novel compound heterozygote mutations (H234Q/R1206X) of the ADAMTS13 gene in an adult patient with Upshaw-Schulman syndrome showing predominant episodes of repeated acute renal failure. Nephrol Dial Transplant ;

6 7. de Mattos AM, Prather J, Olyaei AJ, Shibagaki Y, Keith DS, Mori M, Norman DJ, Becker T. Cardiovascular events following renal transplantation: role of traditional and transplant-specific risk factors. Kidney Int. 2006;70: Shibagaki Y, Tai C, Nayak A, Wahba I. Abdominal compartment syndrome as a common but under-recognized cause of acute renal failure: Report of 5 cases and review of literature. Nephrol Dial Transplant. 2006; 21: Shibagaki Y, and Fujita T. Thrombotic Microangiopathy in Malignant Hypertension and HUS (hemolytic uremic syndrome) / TTP (thrombotic thrombocytopenic purpura) : Can We Differentiate One from the Other? Hypertens Res 2005; 28: Kishi Y, Murashige N, Kami M, Miyakoshi S, Shibagaki Y, Hamaki T, Takaue Y, Taniguchi, S. for the Tokyo Stem Cell Transplantation (SCT) Consortium. Optimal initial dose of oral cyclosporine in relation to its toxicities for graft-versus-host disease prophylaxis following reduced-intensity stem cell transplantation in Japanese patients. Bone Marrow Transplant. 2005; 35: Nishi H, Shibagaki Y, Hatakeyama S, Ito T, Nagata T, Tojo A, Nangaku M, Fujita T. Metastatic intracranial subdural empyema from renal cyst infection in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 2005; 20: Ando K, Takahashi K, Shibata S, Matsui H, Fujita M, Shibagaki Y, Shimosawa T, Isshiki M, Fujita T. Two cases of renovascular hypertension and ischemic renal dysfunction: reliable choice of examinations and treatments. Hypertens Res.2004; 27: Shibagaki Y, Shetty A. Anemia is Common after Renal Transplantation, especially among African Americans. Nephrol Dial Transplant. 2004; 19: 濱 野 高 行 (1 期 生 ) 35. Hamano T, Nakano C, Fujii N, Matsui I, Tomida K, Mikami S, Inoue K, Obi Y, Shimomura A, Okada N, Rakugi H, Isaka Y, Tsubakihara Y. Reply to "FGF23 adds value to risk prediction in patients with chronic kidney disease" Bone in press 34. Taniguchi M, Fukagawa M, Fujii N, Hamano T, Shoji T, Yokoyama K, Nakai S, Shigematsu T, Iseki K, Tsubakihara Y; Committee of Renal Data Registry of the Japanese Society for Dialysis Therapy. Serum phosphate and calcium should be primarily and consistently controlled in prevalent hemodialysis patients. Ther Apher Dial Apr;17(2): Inoue K, Hamano T, Nango N, Matsui I, Tomida K, Mikami S, Fujii N, Nakano C, Obi Y, Shimomura A, Kusunoki Y, Rakugi H, Isaka Y, Tsubakihara Y. Multidetector-row computed tomography is useful to evaluate the therapeutic effects of bisphosphonates in glucocorticoid-induced osteoporosis. cvbfrhg in press 32. Lesher AM, Zhou L, Kimura Y, Sato S, Gullipalli D, Herbert AP, Barlow PN, Eberhardt HU, Skerka C, Zipfel PF, Hamano T, Miwa T, Tung KS, Song WC. Combination of factor h mutation and properdin deficiency causes severe c3 glomerulonephritis. J Am Soc Nephrol Jan;24(1): Liu KD, Yang W, Anderson AH, Feldman HI, Demirjian S, Hamano T, He J, Lash J, Lustigova E, Rosas SE, Simonson MS, Tao K, Hsu CY; on behalf of the Chronic Renal Insufficiency Cohort (CRIC) study investigators. Urine neutrophil gelatinase-associated 5

7 lipocalin levels do not improve risk prediction of progressive chronic kidney disease. Kidney Int May;83(5): Scialla JJ, Lau WL, Reilly MP, Isakova T, Yang HY, Crouthamel MH, Chavkin NW, Rahman M, Wahl P, Amaral AP, Hamano T, Master SR, Nessel L, Chai B, Xie D, Kallem RR, Chen J, Lash JP, Kusek JW, Budoff MJ, Giachelli CM, Wolf M. Fibroblast Growth Factor 23 and Arterial Calcification in the Chronic Renal Insufficiency Cohort Study. Kidney Int Jun;83(6): Nakai S, Iseki K, Itami N, Ogata S, Kazama JJ, Kimata N, Shigematsu T, Shinoda T, Shoji T, Suzuki K, Taniguchi M, Tsuchida K, Nakamoto H, Nishi H, Hashimoto S, Hasegawa T, Hanafusa N, Hamano T, Fujii N, Masakane I, Marubayashi S, Morita O, Yamagata K, Wakai K, Wada A, Watanabe Y, Tsubakihara Y. An overview of regular dialysis treatment in Japan (as of 31 December 2010). Ther Apher Dial Dec;16(6): Tomida K, Hamano T, Ichimaru N, Fujii N, Matsui I, Nonomura N, Tsubakihara Y, Rakugi H, Takahara S, Isaka Y. Dialysis vintage and parathyroid hormone level, not fibroblast growth factor-23, determines chronic-phase phosphate wasting after renal transplantation. Bone Oct; 51(4): Obi Y, Ichimaru N, Hamano T, Tomida K, Matsui I, Fujii N, Okumi M, Kaimori JY, Yazawa K, Kokado Y, Tsubakihara Y, Nonomura N, Rakugi H, Takahara S, Isaka Y. Orally Active Vitamin D for Potential Chemoprevention of Post-transplant Malignancy. Cancer Prev Res 2012 Oct; 5(10): Nakano C, Hamano T, Fujii N, Obi Y, Matsui I, Tomida K, Mikami S, Inoue K, Shimomura A, Nagasawa Y, Okada N, Tsubakihara Y, Rakugi H, Isaka Y. Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysis. Bone Jun; 50(6): Nakano C, Hamano T, Fujii N, Matsui I, Tomida K, Mikami S, Inoue K, Obi Y, Okada N, Tsubakihara Y, Isaka Y, Rakugi H. Combined Use of Vitamin D Status and FGF23 for Risk Stratification of Renal Outcome. Clin J Am Soc Nephrol May; 7(5): Fukagawa M, Komaba H, Hamano T. Vitamin D supplementation in renal disease: Is calcitriol all that is needed? Scand J Clin Lab Invest Suppl Apr; 243: Nakai S, Iseki K, Itami N, Ogata S, Kazama JJ, Kimata N, Shigematsu T, Shinoda T, Shoji T, Suzuki K, Taniguchi M, Tsuchida K, Nakamoto H, Nishi H, Hashimoto S, Hasegawa T, Hanafusa N, Hamano T, Fujii N, Masakane I, Marubayashi S, Morita O, Yamagata K, Wakai K, Wada A, Watanabe Y, Tsubakihara Y. Overview of regular dialysis treatment in Japan (as of 31 December 2009). Ther Apher Dial Feb; 16(1): Reese PP, Bloom RD, Feldman HI, Huverserian A, Thomasson A, Shults J, Hamano T, Goral S, Shaked A, Olthoff K, Rickels MR, Bleicher M, Leonard MB. Changes in vitamin D binding protein and vitamin D concentrations associated with liver transplantation. Liver Int Feb; 32(2): Taniguchi M, Tanaka M, Hamano T, Nakanishi S, Fujii H, Kato H, Koiwa F, Ando R, Kimata N, Akiba T, Kono T, Yokoyama K, Shigematsu T, Kakuta T, Kazama JJ, Tominaga Y, Fukagawa M. Comparison between whole and intact parathyroid hormone assays. Ther Apher Dial Jun; 15 Suppl 1:

8 20. Hamano T, Fujii N, Matsui I, Nakano C, Inoue K, Tomida K, Mikami S, Okada N, Tsubakihara Y, Rakugi H, Isaka Y The Guideline-Practice Gap in the Management of Predialysis CKD-MBD in Japan Ther Apher Dial Jun; 15 Suppl 1: Nakai S, Suzuki K, Masakane I, Wada A, Itami N, Ogata S, Kimata N, Shigematsu T, Shinoda T, Syouji T, Taniguchi M, Tsuchida K, Nakamoto H, Nishi S, Nishi H, Hashimoto S, Hasegawa T, Hanafusa N, Hamano T, Fujii N, Marubayashi S, Morita O, Yamagata K, Wakai K, Watanabe Y, Iseki K, Tsubakihara Y. Overview of Regular Dialysis Treatment in Japan (as of 31 December 2008). Ther Apher Dial Dec;14(6): Hamano T, Matsui I, Mikami S, Tomida K, Fujii N, Imai E, Rakugi H, Isaka Y. Fetuin-mineral complex reflects extraosseous calcification stress in CKD. J Am Soc Nephrol Nov;21(11): Yamamoto R, Nagasawa Y, Shoji T, Iwatani H, Hamano T, Kawada N, Inoue K, Uehata T, Kaneko T, Okada N, Moriyama T, Horio M, Yamauchi A, Tsubakihara Y, Imai E, Rakugi H, Isaka Y. Cigarette Smoking and Progression of IgA nephropathy. Am J Kidney Dis 2010 Aug;56(2): Tanaka H, Hamano T, Fujii N, Tomida K, Matsui I, Mikami S, Nagasawa Y, Ito T, Moriyama T, Horio M, Imai E, Isaka Y, Rakugi H. The impact of diabetes mellitus on vitamin D metabolism in predialysis patients. Bone Nov; 45(5): Hamano T, Tomida K, Mikami S, Matsui I, Fujii N, Imai E, Rakugi H, Isaka Y. Usefulness of bone resorption markers in hemodialysis patients. Bone. 2009; 45(Suppl.1):S Tomida K, Hamano T, Mikami S, Fujii N, Okada N, Matsui I, Nagasawa Y, MoriyamaT, Ito T, Imai E, Isaka Y, Rakugi H. Serum 25-hydroxyvitamin D as an independent determinant of 1-84 PTH and bone mineral density in non-diabetic predialysis CKD patients. Bone. 2009; 44(4): Hamano T. Women with a history of preeclampsia should be monitored for the onset and progression of chronic kidney disease. Nat Clin Pract Nephrol. 2009; 5(1): Tanaka H, Nagasawa Y, Matsui I, Hamano T, Iwatani H, Kawada N, Horio M, Ito T, Isaka Y, Imai E. Pharmacokinetics of olmesartan medoxomil in hemodialysis patients: little effect of dialysis upon its pharmacokinetics. Clin Exp Nephrol. 2009; 13(1): Nakai S, Masakane I, Shigematsu T, Hamano T, Yamagata K, Watanabe Y, Itami N, Ogata S, Kimata N, Shinoda T, Syouji T, Suzuki K, Taniguchi M, Tsuchida K, Nakamoto H, Nishi S, Nishi H, Hashimoto S, Hasegawa T, Hanafusa N, Fujii N, Marubayashi S, Morita O, Wakai K, Wada A, Iseki K, and Tsubakihara Y. An Overview of Regular Dialysis Treatment in Japan (As of 31 December 2007). Ther Apher Dial. 2009; 13(6): Matsui I, Hamano T, Mikami S, Fujii N, Takabatake Y, Nagasawa Y, Kawada N, Ito T, Imai E, Rakugi H, and Isaka Y. Fully phosphorylated fetuin-a forms a mineral complex in the serum of rats with adenine-induced renal failure. Kidney Int. 2009; 75(9): Iio K, Nagasawa Y, Kimura T, Yamasaki K, Takeda Y, Hamano T, Iwatani H, Sumitsuji S, Nagai Y, Ito T, Imai E, and Hayashi T. Assessment of coronary stenosis by 16-MDCT in asymptomatic diabetic patients starting dialysis therapy. Nephron Clinical Practice. 7

9 2008;109(2):c Hamano T. Is calcitriol treatment associated with improved survival in predialysis patients with chronic kidney disease? Nature Clinical Practice Nephrology Aug;4(8): Mikami S, Hamano T, Fujii N, Nagasawa Y, Isaka Y, Moriyama T, Matsuhisa M, Ito T, Imai E, Hori M., Serum Osteoprotegerin as a screening tool for Coronary Artery Calcification Score in Diabetic Pre-dialysis patients. Hypertension Research2008. Jun;31(6): Nakai S, Masakane I, Akiba T, Iseki K, Watanabe Y, Itami N, Kimata N, Shigematsu T, Shinoda T, Syoji T, Syoji T, Suzuki K, Tsuchida K, Nakamoto H, Hamano T, Marubayashi S, Morita O, Morozumi K, Yamagata K, Yamashita A, Wakai K, Wada A, Tsubakihara Y. Overview of Regular Dialysis Treatment in Japan (as of 31 December 2005). Ther Apher Dial Dec;11(6): Hamano T. Daily versus thrice-weekly hemodialysis for phosphorus control. Nature Clinical Practice Nephrology Jul;3(7): Fujii N, Hamano T, Mikami S, Nagasawa Y, Isaka Y, Moriyama T, Horio M, Imai E, Hori M, Ito T.Risedronate. an effective treatment for glucocorticoid-induced bone loss in CKD patients with or without concomitant active vitamin D (PRIUS-CKD). Nephrol Dial Transplant. 2007; 22: Hamano T, Fujii N, Ito T, Nagasawa Y, Isaka Y, Moriyama T, Horio M, Okada N, Imai E. Serum NTX is a practical marker for assessing antiresorptive therapy for glucocorticoid treated patients with chronic kidney disease. Bone. 2006; 39(5): Hamano T, Fujii N, Ito T, Imai E. Different routes bridging calcium in Japanese hemodialysis patients. Ther Apher Dial. 2005; 9(1): Hamano T, Oseto S, Fujii N, Ito T, Katayama M, Horio M, Imai E, Hori M. Impact of lowering dialysate calcium concentration on serum bone turnover markers in hemodialysis patients. Bone. 2005; 36(5): 小 松 弘 幸 (1 期 生 ) 10. Komatsu H, Fujimoto S, Kikuchi M, Sato Y, Kitamura K. Tonsillectomy delays progression of advanced IgA nephropathy to end-stage kidney disease. Ren Fail 2012; 34: Komatsu H, Fujimoto S. Tonsillectomy combined with steroid pulse therapy induces clinical remission of IgA nephropathy. Adv Otorhinolaryngol 2011; 72: Komatsu H, Fujimoto S, Hara S, Fukuda A, Fukudome K, Yamada K, Sato Y, Kitamura K. Recent therapeutic strategies improve renal outcome in patients with IgA nephropathy. Am J Nephrol 2009; 30: Nishiura R, Kita T, Yamada K, Komatsu H, Hara S, Sato Y, Fujimoto S. Radial augmentation index is related to cardiovascular risk in hemodialysis patients. Ther Apher Dial 2008; 12: Komatsu H, Fujimoto S, Hara S, Sato Y, Yamada K, Kitamura K. Effect of tonsillectomy 8

10 plus steroid pulse therapy on clinical remission of IgA nephropathy: A controlled study. Clin J Am Soc Nephrol. 2008;3(5): Yamada K, Fujimoto S, Nishiura R, Komatsu H, Tatsumoto M, Sato Y, Hara S, Hisanaga S, Ochiai H, Nakao H, Eto T. Risk factors of the progression of abdominal aortic calcification in patients on chronic haemodialysis. Nephron Dial Trasplant 2007; 22: Uezono S, Hara S, Sato Y, Komatsu H, Ikeda N, Shimao Y, Hayashi T, Asada Y, Fujimoto S, Eto T. Renal biopsy in elderly patients: A clinicopathological analysis. Ren Fail 2006; 28: Komatsu H, Fujimoto S, Hara S, Nakao H, Sato Y, Yamada K, Eto T. Multivariate analysis of prognostic factors and effect of treatment in patients with IgA nephropathy. Ren Fail 2005; 27: Komatsu H, Fujimoto S, Sato Y, Hara S, Morita S, Yamada K, Eto T. Point of no return (PNR) in progressive IgA nephropathy: Significance of blood pressure and proteinuria management up to PNR. J Nephrol. 2005; 18: Komatsu H, Fujimoto S, Hara S, Sato Y, Yamada K, Eto T. Relationship between serum IgA/C3 ratio and progression of IgA nephropathy. Intern Med 2004; 43: 石 川 英 二 (2 期 生 ) 3. Ito T, Ishikawa E, Matsuda Y, Tanoue A, Fujimoto M, Matsuo H, Murata T, Hiramoto T, Ito M, Nomura S. Elevated serum levels of bromine do not always indicate pseudohyperchloremia.clin Exp Nephrol. 2010; 14, Ishikawa E, Nomura S, Hamaguchi T, Obe T, Inoue-Kiyohara M, Oosugi K, Katayama K, Ito M. Ultrasonography as a predictor of overt bleeding after renal biopsy. Clin Exp Nephrol. 2009;13: Ishikawa E, Nomura S, Obe T, Katayama K, Oosugi K, Murata T, Tanoue A, Fujimoto M, Matsuo H, Ito M. How long is strict bed rest necessary after renal biopsy? Clin Exp Nephrol. 2009; 13: 金 森 弘 志 (2 期 生 ) 7. Kanamori H, Nagai K, Matsubara T, Mima A, Yanagita M, Iehara N, Takechi H, Fujimaki K, Usami K, Fukatsu A, Kita T, Matsubayashi K, Arai H. Comparison of the psychosocial quality of life in hemodialysis patients between the elderly and non-elderly using a visual analogue scale: The importance of appetite and depressive mood. Geriatr Gerontol Int Jan;12(1): Kanamori H, Yanagita M, Nagai K, Matsubara T, Takechi H, Fujimaki K, Hara A, Usami K, Fukatsu A, Kita T, Matsubayashi K, Arai H. Psychosocial quality of life of elderly hemodialysis patients using visual analog scale: Comparison with healthy elderly in Japan. Journal of Clinical Gerontology and Geriatrics 2011; Kanamori H, Toma M, Fukatsu A. Improvement of renal function after opening occluded atherosclerotic renal arteries. J Invasive Cardiol Sep;21(9):E Mima A, Ichida K, Matsubara T, Kanamori H, Inui E, Tanaka M, Manabe Y, Iehara N, Tanaka Y, Yanagita M, Yoshioka A, Arai H, Kawamura M, Usami K, Hosoya T, Kita T, 9

11 Fukatsu A. Acute renal failure after exercise in a Japanese sumo wrestler with renal hypouricemia. Am J Med Sci Dec;336(6): Mima A, Arai H, Matsubara T, Abe H, nagai K, Tamura Y, Torikoshi K, Araki M, Kanamori H, Takahashi T, Tominaga T, Matsuura M, Iehara N, Fukatsu A, KitaT, Doi T. Urinary Smad1 is a novel marker to predict later onset of mesangial matrix expansion in diabetic nephropathy. Diabetes Jun;57(6): Kanamori H, Matsubara T, Mima A, Sumi E, Nagai K, Takahashi T, Abe H, Iehara N, Fukatsu A, Okamoto H, Kita T, Doi T, Arai H. Inhibition of MCP-1/CCR2 pathway ameliorates the development of diabetic nephropathy. Biochem Biophys Res Commun Sep 7;360(4): Kanamori H, Ota M, Takeoka H, Osafune K, Yonezu S, Fukatsu A, Kanatsu K. IgM-immune complex glomerulonephritis associated with sarcoidosis. Clin Exp Nephrol Mar;10(1): 木 村 久 仁 子 (2 期 生 ) 1. Kimura K, Yamaguchi Y, Horii M, Kawata H, Yamamoto H, Uemura S, Saito Y. ANP is Cleared Much Faster than BNP in Patients with Congestive Heart Failure. Eur J Clin Pharmacol Jul;63(7): 篠 原 加 代 (2 期 生 ) 5. Tsuchikura S, Shoji T, Kimoto E, Shinohara K,Hatsuda S, Koyama H,Emoto M, Nishizawa Y. Brachial-ankle pulse wave velocity as an index of central arterial stiffness. J Atheroscler Thromb. 2010;17(6): Tsuchikura S, Shoji T, Kimoto E, Shinohara K,Hatsuda S, Koyama H,Emoto M, Nishizawa Y. Central versus peripheral arterial stiffness in association with coronary, cerebral and peripheral arterial disease. Atherosclerosis. 2010;211(2): Hiroki Ueno, Hidenori Koyama Shinji Tanaka, Shinya Fukumoto, Kayo Shinohara, Tetsuo Shoji, Masanori Emoto, Hideki Tahara, Ryusuke Kakiya, Tsutomu Tabata, Toshio Miyata, Yoshiki Nishizawa. Skin autofluorescence, a marker for advanced glycation end product accumulation, is associated with arterial stiffness in patients with end-stage renal disease. Metabolism 2008:57(10), Kimoto E, Shoji T, Shinohara K, et al.: Regional arterial stiffness in patients with type 2 diabetes and chronic kidney disease. J Am Soc Nephrol.2006:17(8): Shinohara K, Shoji T, Kimoto E, Yokoyama H, Fujiwara S, Hatsuda S, Maeno T, Shoji T, Fukumoto S, Emoto M, Koyama H, Nishizawa Y. Effect of atorvastatin on regional arterial stiffness in patients with type 2 diabetes mellitus. J Atheroscler Thromb. 2005;12(4): 玉 垣 圭 一 (2 期 生 ) 4. Shiotsu Y, Mori Y, Nishimura M, Hatta T, Imada N, Maki N, Iida K, Iwamoto N, Matsuoka E, Tamagaki K, Kosaki A. Prognostic utility of plasma S100A12 levels to establish a novel scoring system for predicting mortality in maintenance hemodialysis patients: a two-year prospective observational study in Japan. BMC Nephrol. 2013; 14: Shimizu H, Ichikawa D, Tamagaki K, Komatsu S, Kubota T, Okamoto K, Shiozaki A, 10

12 Fujiwara H, Ota N, Otsuji E. Evaluation of postoperative nephrolithiasis and renal dysfunction in gastric cancer patients. Gastric Cancer. 2013; 16(3): Shiotsu Y, Mori Y, Nishimura M, Sakoda C, Tokoro T, Hatta T, Maki N, Iida K, Iwamoto N, Ono T, Matsuoka E, Kishimoto N, Tamagaki K, Matsubara H, Kosaki A. Plasma S100A12 level is associated with cardiovascular disease in hemodialysis patients. Clin J Am Soc Nephrol. 2011; 6(4): Shiotsu Y, Mori Y, Hatta T, Maki N, Iida K, Matsuoka E, Kado H, Ishida R, Kishimoto N, Tamagaki K, Nishimura M, Iwamoto N, Ono T, Matsubara H, Kosaki A. Plasma S100A12 levels and peripheral arterial disease in end-stage renal disease. Nephron Extra. 2011; 1(1): 戸 田 晋 (2 期 生 ) 2. Susumu Toda, Yasuhiko Ito, Masashi Mizuno, Yasuhiro Suzuki, Isao Ito, Hideki Hiramatsu,Takenori Ozaki, Naotake Tsuboi, Waichi Sato, Shoichi Maruyama, Enyu Imai and Seiichi Matsuo. Asymptomatic diverticulosis identified by computed tomography is not a risk factor for enteric peritonitis. Nephrol Dial Transplant (2012) 27: Akiho Sawai, Yasuhiko Ito, Masashi Mizuno, Yasuhiro Suzuki, Susumu Toda, Isao Ito,Ryohei Hattori, Yoshihisa Matsukawa, Momokazu Gotoh, Yoshifumi Takei, Yukio Yuzawa and Seiichi Matsuo. Peritoneal macrophage infiltration is correlated with baseline peritoneal solute transport rate in peritoneal dialysis patients. Nephrol Dial Transplant (2011) 26: 藤 井 直 彦 (2 期 生 ) 5. Chikako Nakano, Takayuki Hamano, Naohiko Fujii, Isao Matsui, Kodo Tomida, Satoshi Mikami, Kazunori Inoue, Yoshitsugu Obi, Noriyuki Okada, Yoshiharu Tsubakihara, Yoshitaka Isaka, and Hiromi Rakugi, Combined Use of Vitamin D Status and FGF23 for Risk Stratification of Renal Outcome, Clin J Am Soc Nephrol 7: , Fujii N, Hamano T, Mikami S, Nagasawa Y, Isaka Y, Moriyama T, Horio M, Imai E, Hori M, Ito T. Risedronate, an effective treatment for glucocorticoid-induced bone loss in CKD patients with or without concomitant active vitamin D (PRIUS-CKD). Nephrol Dial Transplant. 2007; 22: Hamano T, Fujii N, Ito T, Nagasawa Y, Isaka Y, Moriyama T, Horio M, Okada N, Imai E. Serum NTX is a practical marker for assessing antiresorptive therapy for glucocorticoid treated patients with chronic kidney disease. Bone. 2006; 39(5): Hamano T, Fujii N, Ito T, Imai E. Different routes bridging calcium in Japanese hemodialysis patients. Ther Apher Dial. 2005; 9(1): Hamano T, Oseto S, Fujii N, Ito T, Katayama M, Horio M, Imai E, Hori M. Impact of lowering dialysate calcium concentration on serum bone turnover markers in hemodialysis patients. Bone. 2005; 36(5): 古 松 慶 之 (2 期 生 ) 10. Nakajima F, Morimoto S, Yurugi T, Amari Y, Kasuno Y, Fukui M, Furumatsu Y, Kitamura T. Increment of cerebral blood flow by LDL-apheresis in dialysis patients with arteriosclerosis obliterans: a pilot study. Int J Artif Organs. 2012; 35(11): Furumatsu Y, Nagasawa Y, Shoji T, Yamamoto R, Iio K, Matsui I, Takabatake Y, Kaimori 11

13 JY, Iwatani H, Kaneko T, Tsubakihara Y, Imai E, Isaka Y, Rakugi H. Urinary type IV collagen in nondiabetic kidney disease. Nephron Clin Pract. 2011; 117(2):c Furumatsu Y, Nagasawa Y, Yamamoto R, Iio K, Iwatani H, Matsui I, Takabatake Y, Kawada N, Shoji T, Imai E, Isaka Y, Rakugi H. Specialist care and improved long-term survival of dialysis patients. Nephrol Dial Transplant. 2010; 25(6): Inoue K, Nagasawa Y, Yamamoto R, Omori H, Kimura T, Tomida K, Furumatsu Y, Imai E, Isaka Yo and Rakugi H. Severe adverse effects of 5-fluorouracil in S-1 were lessened by haemodialysis due to elimination of the drug. NDT Plus. 2009; 2: Yamamoto R, Nagasawa Y, Marubashi S, Furumatsu Y, Iwatani H, Iio K, Matsui I, Dono K, Imai E, Monden M, Isaka Y. Early intervention of plasma exchange against liver failure after adult-to-adult living related liver transplantation. Blood Purification. 2009; 28: Furumatsu Y, Nagasawa Y, Hamano T, Iwatani H and Imai E. Acute renal failure with severe loin pain after anaerobic exercise (ALPE): detection of patchy renal ischaemia by contrast-enhanced colour Doppler. Nephrology Dialysis Transplantation Plus. 2008; 2: Furumatsu Y, Nagasawa Y, Hamano T, Iwatani H, Iio K, Shoji T, Ito T, Tsubakihara Y and Imai E. Integrated therapies including erythropoietin decrease the incidence of dialysis: lessons from mapping the incidence of end-stage renal disease in Japan. Nephrology Dialysis Transplantation. 2008; 23: Furumatsu Y, Nagasawa Y, Tomida K, Mikami S, Kaneko T, Okada N, Tsubakihara Y, Imai E and Shoji T. Effect of Renin-Angiotensin-Aldosterone System Triple Blockade on Non-Diabetic Renal Disease: Addition of Aldosterone Blocker, Spironolactone, to Angiotensin-Converting-Enzyme Inhibitor and Angiotensin-II Receptor Blocker Combination. Hypertension Research. 2008; 31: Furumatsu Y and Imai E. Albuminuria is associated with the incidence of some cancers in nondiabetic individuals. Nature Reviews Nephrology. 2008; 4: Shoji T, Wada A, Inoue K, Hayashi D, Tomida K, Furumatsu Y, Kaneko T, Okada N, Fukuhara Y, Imai E, Tsubakihara Y. Prospective randomized study evaluating the efficacy of the spherical adsorptive carbon AST-120 in chronic kidney disease patients with moderate decrease in renal function. Nephron Clin Pract. 2007;105(3):c Epub 2006 Dec 15. 本 間 康 一 郎 (2 期 生 ) 31. Homma K, Hayashi K, Wakino S, Tokuyama H, Kanda T, Tatematsu S, Hasegawa K, Fujishima S, Hori S, Saruta T, Itoh H. Rho Kinase Activity during Pressure-induced Constriction of Renal Microvessels. Keio J Med in press 30. Homma K, Homma Y, Shiina Y, Wakino S, Suzuki M, Fujishima S, Hayashi K, Hori S, Itoh H. Skew of plasma LDL and HDL distributions to less-dense subfractions in normotriglyceridemic CKD patients on maintenance hemodialysis treatment. Nephron Clin Pract. in press corresponding author 29. Morizane R, Monkawa T, Fujii S, Yamaguchi S, Homma K, Okano H, Itoh H. Kidney specific protein-positive cells derived from embryonic stem cells reproduce tubular 12

14 structures in vitro and differentiate into renal tubular cells. PLoS One. in press Hirowatari Y, Homma Y, Yoshizawa J, Homma K. Increase of electronegative-ldl-fraction ratio and IDL-cholesterol in chronic kidney disease patients with hemodialysis treatment. Lipids Health Dis corresponding author 27. Homma K, Homma Y, Yamaguchi S, Shiina Y, Wakino S, Hayashi K, Hori S, Itoh H. Triglyceride-rich lipoproteins in chronic kidney disease patients undergoing maintenance haemodialysis treatment. Int J Clin Pract corresponding author 26. Yamaguchi S, Yamahara K, Homma K, Suzuki S, Fujii S, Morizane R, Monkawa T, Matsuzaki Y, Kangawa K, Itoh H. The role of microrna-145 in human embryonic stem cell differentiation into vascular cells. Atherosclerosis 219: , Tokuyama H, Wakino S, Hara Y, Washida N, Fujimura K, Hosoya K, Yoshioka K, Hasegawa K, Minakuchi H, Homma K, Hayashi K, Itoh H. Role of mineralocorticoid receptor/rho/rho-kinase pathway in obesity-related renal injury. Int J Obes (Lond). 1-10, Washida N, Wakino S, Tonozuka Y, Homma K, Tokuyama H, Hara Y, Hasegawa K, Minakuchi H, Fujimura K, Hosoya K, Hayashi K, Itoh H. Rho-kinase inhibition ameliorates peritoneal fibrosis and angiogenesis in a rat model of peritoneal sclerosis. Nephrol Dial Transplant. 26: , Hara Y, Wakino S, Tanabe Y, Saito M, Tokuyama H, Washida N, Tatematsu S, Yoshioka K, Homma K, Hasegawa K, Minakuchi H, Fujimura K, Hosoya K, Hayashi K, Nakayama K, Itoh H. Rho and Rho-kinase activity in adipocytes contributes to a vicious cycle in obesity that may involve mechanical stretch. Sci Signal. 4: ra3, Homma Y, Michishita I, Hayashi H, Shigematsu H; Kanagawa Lipid Research Group.Effects of low-dose simvastatin on the distribution of plasma cholesterol and oxidized low-density lipoprotein in three ultra-centrifugally separated low-density lipoprotein subfractions: 12- month, open-label trial. J Atheroscler Thromb. 27: , Homma K, Sone M, Taura D, Yamahara K, Suzuki Y, Takahashi K, Sonoyama T, Inuzuka M, Fukunaga Y, Tamura N, Itoh H, Yamanaka S, Nakao K. Human ES- and ips-derived vascular endothelial cells show greater functionality than adult endothelial cells due to greater expression of Sirt1. Atherosclerosis. 212: 42-47, Morita Y, Homma Y, Igarashi M, Miyano R, Yamaguchi H, Matsuda M, Tanigaki T, Shiina Y, Homma K. Decrease in glomerular filtration rate by plasma low-density lipoprotein cholesterol in subjects with normal kidney function assessed by urinalysis and plasma creatinine. Atherosclerosis. 210: , Hayashi K, Homma K, Wakino S, Tokuyama H, Sugano N, Saruta T, Itoh H. T-type ca channel blockade as a determinant of kidney protection. Keio J Med. 59: 84-95, Taura D, Sone M, Homma K, Oyamada N, Takahashi K, Tamura N, Yamanaka S, Nakao K. Induction and Isolation of Vascular Cells from Human Induced Pluripotent Stem Cells. Arterioscler Thromb Vasc Biol. 29: , Taura D, Noguchi M, Sone M, Hosoda K, Mori E, Okada Y, Takahashi K, Homma K, Oyamada N, Inuzuka M, Sonoyama T, Ebihara K, Tamura N, Itoh H, Suemori H, 13

15 Nakatsuji N, Okano H, Yamanaka S, Nakao K. Adipogenic differentiation of human induced pluripotent stem cells: Comparison with that of human embryonic stem cells. FEBS Lett. 583: , Yamahara K, Sone M, Itoh H, Yamashita J, Yurugi-Kobayashi T, Ting-Hsing Chao, Homma K, Chao TH, Miyashita K, Park K, Oyamada N, Sawada N, Fukunaga Y, Tamura N, Nakao K. Augmentation of Neovascularizaiton in Hindlimb Ischemia by Combined Transplantation of Human Embryonic Stem Cells-derived Endothelial and Mural Cells. PLoS ONE 3: e1666, Yoshioka K, Wakino S, Homma K, Kanda T, Tatematsu S, Hasegawa K, Sugano N, Ito O, Omata K, Saruta T, Hayashi K. Renal Cytochrome P450 as a Determinant of Impaired Natriuresis by PPARg Ligands in Ovariectomized Obese Rats. Obesity Research 16: , Sugano N, Wakino S, Kanda T, Tatematsu S, Homma K, Yoshioka K, Hasegawa K, Hara Y, Suetsugu Y, Yoshizawa T, Utsunomiya Y, Tokudome G, Hosoya T, Saruta T, Hayashi K. T-type calcium channel blockade as a therapeutic strategy against renal injury in rats with subtotal nephrectomy. Kidney Int. 73: , Tatematsu S, Wakino S, Kanda T, Homma K, Yoshioka K, Hasegawa K, Sugano N, Kimoto M, Saruta T, Hayashi K. Role of nitric oxide-producing and -degrading pathways in coronary endothelial dysfunction in chronic kidney disease. J Am Soc Nephrol. 2007;18: Hasegawa K, Wakino S, Tatematsu S, Yoshioka K, Homma K, Sugano N, Kimoto M, Hayashi K, Itoh H. Role of asymmetric dimethylarginine in vascular injury in transgenic mice overexpressing dimethylarginie dimethylaminohydrolase 2. Circ Res. 101: e2-10, Hayashi K, Wakino S, Sugano N, Ozawa Y, Homma K, Saruta T. Ca2+ channel subtypes and pharmacology in the kidney. Circ Res. 100: , Hasegawa K, Wakino S, Tanaka T, Kimoto M, Tatematsu S, Kanda T, Yoshioka K, Homma K, Sugano N, Kuribayashi M, Saruta T, Hayashi K. Dimethylarginine Dimethylaminohydrolase 2 Increases Vascular Endothelial Growth Factor Expression Through Sp1 Transcription Factor in Endothelial Cells. Arterioscler Thromb Vasc Biol. 26: , Homma K, Hayashi K, Wakino S, Saruta T. Primary Malignant Hepatic Pheochromocytoma with Negative Adrenal Scintigraphy. Hypertens Res. 2006; 29: Hayashi K, Wakino S, Kanda T, Homma K, Sugano N, Saruta T. Molecular mechanisms and therapeutic strategies of chronic renal injury: role of rho-kinase in the development of renal injury. J Pharmacol Sci. 100: 29-33, Hasegawa K, Wakino S, Kanda T, Yoshioka K, Tatematsu S, Homma K, Takamatsu I, Sugano N, Hayashi K. Divergent action of calcium channel blockers on ATP-binding cassette protein expression. J Cardiovasc Pharmacol. 46: , Hayashi K, Wakino S, Homma K, Sugano N, Saruta T. Pathophysiological significance of T-type Ca2+ channels: role of T-type Ca2+ channels in renal microcirculation. J Pharmacol Sci. 99: ,

16 5. Kanda T, Wakino S, Homma K, Yoshioka K, Tatematsu S, Hasegawa K, Takamatsu I, Sugano N, Hayashi K, Saruta T. Rho-kinase as a molecular target for insulin resistance and hypertension. FASEB J. 20: , Wakino S, Hayashi K, Tatematsu S, Hasegawa K, Takamatsu I, Kanda T, Homma K, Yoshioka K, Sugano N, Saruta T. Pioglitazone lowers systemic asymmetric dimethylarginine by inducing dimethylarginine dimethylaminohydrolase in rats. Hypertens Res. 28: , Hayashi K, Wakino S, Ozawa Y, Homma K, Kanda T, Okubo K, Takamatsu I, Tatematsu S, Kumagai H, Saruta T. Role of protein kinase C in Ca channel blocker-induced renal arteriolar dilation in spontaneously hypertensive rats--studies in the isolated perfused hydronephrotic kidney. Keio J Med. 54: , Kanda T, Hayashi K, Wakino S, Homma K, Yoshioka K, Hasegawa K, Sugano N, Tatematsu S, Takamatsu I, Mitsuhashi T, Saruta T. Role of Rho-kinase and p27 in angiotensin II-induced vascular injury. Hypertension. 45: , Ichihara A, Hayashi M, Kaneshiro Y, Takemitsu T, Homma K, Kanno Y, Yoshizawa M, Furukawa T, Takenaka T, Saruta T. Low doses of losartan and trandolapril improve arterial stiffness in hemodialysis patients. Am J Kidney Dis. 2005; 45: 西 裕 志 (3 期 生 ) 7. Nishi H, Shibagaki Y, Kido R, Tamura S, Nangaku M, Sugawara Y, Fujita T: Chronic renal outcome after living donor liver transplantation. Clin Transplant. 2013; 27: Mimura I, Nishi H, Nishi T, Mise N, Sugimoto T. Malnutrition and inflammation determine prognosis of patients with CRS type 4. Blood Purif. 2011; 31: Mimura I, Nishi H, Mise N, Mori M, Sugimoto T. Left ventricular geometry and cardiovascular mortality based on haemodialysis patient autopsy analyses. Nephrology (Carlton). 2010; 15: Nishi H, Shibagaki Y, Hirano K, Akahane M, Kido R, Nangaku M, Kaname S, Sasahira N, Isayama H, Tada M, Tsukamoto R, Ohtomo K, Omata M, Fujita T. Laboratory and imaging features of kidney involvement in autoimmune pancreatitis: incidence, correlation, and steroid therapy response. Clin Nephrol. 2010; 73: Nishi H, Tojo A, Onozato ML, Jimbo R, Nangaku M, Uozaki H, Hirano K, Isayama H, Omata M, Kaname S, Fujita T. Anti-carbonic anhydrase II antibody in autoimmune pancreatitis and tubulointerstitial nephritis. Nephrol Dial Transplant. 2007; 22: Nangaku M, Nishi H, Fujita T. Pathogenesis and prognosis of thrombotic microangiopathy. Clin Exp Nephrol. 2007; 11: Nishi H, Tomida C, Gotoh M, Yamagata K, Akiyama H, Shimokama T. Chronic renal failure with severe mesangiolysis in a hematopoietic stem cell transplant recipient. Ren Fail. 2006; 28: 吾 郷 里 華 (3 期 生 ) 1. Rika Ago, Ayumu Nakashima, Takayuki Naito, Shigehiro Doi, Mariko Ochiai, Naoki Hamaguchi, Yukio Yokoyama, Junko Tanaka, Noriaki Yorioka, Takao Masaki, and 15

17 Nobuoki Kohno. Morning blood pressure is useful for detection of left ventricular hypertrophy in hemodialysis patients. clinical and experimental Nephrology (2012)(16)( ) 濵 田 康 弘 (3 期 生 ) 2. Hamada Y, Shinohara Y, Yano M, Yamamoto M, Yoshio M, Satake K, Toda A, Hirai M, Usami M: Effect of the menstrual cycle on serum diamine oxidase levels in healthy women. Clin Biochem. 2013;46(1-2): Usami M, Miyoshi M, Kanbara Y, Aoyama M, Sakaki H, Shuno K, Hirata K, Takahashi M, Ueno K, Hamada Y, Tabata S, Asahara T, Nomoto K: Analysis of fecal microbiota, organic acids and plasma lipids in hepatic cancer patients with or without liver cirrhosis. Clin Nutr. 2013; 32(3): 藤 﨑 毅 一 郎 (3 期 生 ) 1. Fujisaki K, Kanai H, Hirakata H, Nakamura S, Koga Y, Hattori F, Iida M. Midodrine hydrochloride and L-threo-3,4-dihydroxy-phenylserine preserve cerebral blood flow in hemodialysis patients with orthostatic hypotension. Ther Apher Dial. 2007; 11: 三 上 聡 司 (3 期 生 ) 1. Mikami S, Hamano T, Fujii N, Nagasawa Y, Isaka Y, Moriyama T, Matsuhisa M, Ito T, Imai E, Hori M.Serum osteoprotegerin as a screening tool for coronary artery calcification score in diabetic pre-dialysis patients. Hypertens Res Jun;31(6): 安 田 宜 成 (3 期 生 ) 24. Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S. Lower serum albumin level is associated with higher fractional excretion of creatinine. Clin Exp Nephrol. in press 23. Hara Y, Noda A, Miyata S, Otake H, Yasuda Y, Okuda M, Koike Y, Nakata S, Nakashima T. Comparison of oxygen desaturation patterns in children and adults with sleep-disordered breathing. Am J Otolaryngol. in press 22. Noda A, Miyata S, Yasuda Y. Therapeutic strategies for sleep apnea in hypertension and heart failure. Pulm Med. 2013; 2013: Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S; Collaborators Developing the Japanese Equation for Estimated GFR. GFR estimation using standardized serum cystatin C in Japan. Am J Kidney Dis Feb;61(2): Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S. Performance of GFR equations in Japanese subjects. Clin Exp Nephrol Jun;17(3): Okumura N, Hayashi M, Imai E, Ishii H, Yoshikawa D, Yasuda Y, Goto M, Matsuo S, Oiso Y, Murohara T. Effects of carperitide on contrast-induced acute kidney injury with a minimum volume of contrast in chronic kidney disease patients. Nephron Extra Jan;2(1): Imai E, Yasuda Y, Matsuo S. A decade after the KDOQI CKD guidelines: a perspective from Japan. Am J Kidney Dis Nov; 60(5): Tatematsu M, Yasuda Y, Morita Y, Sakamoto I, Kurata K, Naruse T, Yamamoto R, Tsuboi N, Sato W, Imai E, Matsuo S, Maruyama S. Complete Remission within Two Years 16

18 Predicts a Good Prognosis after Methylprednisolone Pulse Therapy in Patients with IgA Nephropathy. Clin Exp Nephrol Dec;16(6): Okada R, Yasuda Y, Tsushita K, Wakai K, Hamajima N, Matsuo S. Glomerular hyperfiltration in prediabetes and prehypertension. Nephrol Dial Transplant May;27(5): Horio M, Yasuda Y, Kaimori J, Ichimaru N, Isaka Y, Takahara S, Nishi S, Uchida K, Takeda A, Hattori R, Kitada H, Tsuruya K, Imai E, Takahashi K, Watanabe T, Matsuo S. Performance of the Japanese GFR equation in potential kidney donors. Clin Exp Nephrol Jun;16(3): Ando Y, Kawada K, Inada M, Morita S, Mitsuma A, Yasuda Y, Hiramatsu M, Fujimoto Y, Fujita K. Pharmacokinetic study of S-1 in patients in whom inulin clearance was measured. Oncology. 2012; 83(1): Nakazaki C, Noda A, Yasuda Y, Nakata S, Koike Y, Yasuma F, Murohara T, Nakashima T. Continuous positive airway pressure intolerance associated with elevated nasal resistance is possible mechanism of complex sleep apnea syndrome. Sleep Breath Sep;16(3): Dai SS, Yasuda Y, Zhang CL, Horio M, Zuo L, Wang HY. Evaluation of GFR measurement method as an explanation for differences among GFR estimation equations. Am J Kidney Dis Sep; 58(3): Shimokata T, Ando Y, Yasuda Y, Hamada A, Kawada K, Saito H, Matsuo S, Kondo M, Imaizumi K, Hasegawa Y. Prospective evaluation of pharmacokinetically guided dosing of carboplatin in Japanese patients with cancer. Cancer Sci Dec;101(12): Horio M, Yasuda Y, Takahara S, Imai E, Watanabe T, Matsuo S. Comparison of a simple and a standard method for inulin renal clearance. Clin Exp Nephrol Oct;14(5): Miyagi M, Ishii H, Murakami R, Isobe S, Hayashi M, Amano T, Arai K, Yoshikawa D, Ohashi T, Uetani T, Yasuda Y, Matsuo S, Matsubara T, Murohara T. Impact of renal function on coronary plaque composition. Nephrol Dial Transplant Jan; 25(1): Horio M, Imai E, Yasuda Y, Watanabe T, Matsuo S. Modification of the CKD epidemiology collaboration (CKD-EPI) equation for Japanese: accuracy and use for population estimates. Am J Kidney Dis Jul; 56(1): Mastuo S, Yasuda Y, Imai E, Horio M. Current status of estimated GFR (egfr) equations for Asians and an approach to create a common egfr equation. Nephrology. 2010; 15(Suppl.2): Sukegawa M, Noda A, Yasuda Y, Nakata S, Sugiura T, Miyata S, Honda K, Hasegawa Y, Nakashima T, Koike Y. Impact of microarousal associated with increased negative esophageal pressure in sleep-disordered breathing. Sleep Breath Nov;13(4): Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney 17

19 Dis Jun; 53(6): Horio M, Imai E, Yasuda Y, Hishida A, Matsuo S. Japanese Equation for Estimating GFR.Simple sampling strategy for measuring inulin renal clearance. Clin Exp Nephrol Feb; 13(1): Imai E, Horio M, Iseki K, Yamagata K, Watanabe T, Hara S, Ura N, Kiyohara Y, Hirakata H, Moriyama T, Ando Y, Nitta K, Inaguma D, Narita I, Iso H, Wakai K, Yasuda Y, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S. Prevalence of chronic kidney disease (CKD) in the Japanese general population predicted by the MDRD equation modified by a Japanese coefficient. Clin Exp Nephrol. 2007; 11: Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Hara S, Ura N, Kiyohara Y, Hirakata H, Watanabe T, Moriyama T, Ando Y, Inaguma D, Narita I, Iso H, Wakai K, Yasuda Y, Tsukamoto Y, Ito S, Makino H, Hishida A, Matsuo S. Estimation of Glomerular Filtration Rate by the MDRD Equation Modified for Japanese Patients with Chronic Kidney Disease. Clin Exp Nehrol. 2007; 11: Sugiura T, Noda A, Nakata S, Yasuda Y, Soga T, Miyata S, Nakai S, Koike Y. Influence of nasal resistance on initial acceptance of continuous positive airway pressure in treatment for obstructive sleep apnea syndrome. Respiration. 2007; 74: 若 杉 三 奈 子 (3 期 生 ) 8. Wakasugi M, Kazama JJ, Taniguchi M, Wada A, Iseki K, Tsubakihara Y, Narita I. Increased Risk of Hip Fracture among Japanese Hemodialysis Patients. J Bone Miner Metab 2013 Jan 6. [Epub ahead of print] 7. Wakasugi M, Kazama JJ, Yamamoto S, Kawamura K, Narita I. Cause-specific excess mortality among dialysis patients: A comparison with the general population in Japan. Ther Apher Dial 2012 DEC 11. DOI: /j x [Epub ahead of print] 6. Wakasugi M, Kazama JJ, Kawamura K, Yamamoto S, Narita I. A combination of healthy lifestyle factors is associated with a decreased incidence of chronic kidney disease: a population-based cohort study. Hypertens Res Nov 22. doi: /hr [Epub ahead of print] 5. Wakasugi M, Kazama JJ, Narita I.Use of Japanese society for dialysis therapy dialysis tables to compare the local and national incidence of dialysis. Ther Apher Dial. 2012; 16: Wakasugi M, Narita I, Iseki K, Moriyama T, Yamagata K, Tsuruya K, Yoshida H, Fujimoto S, Asahi K, Kurahashi I, Ohashi Y, Watanabe T. Weight gain after 20 years of age is associated with prevalence of chronic kidney disease. Clin Exp Nephrol. 2012; 16(2): Wakasugi M, Kawamura K, Yamamoto S, Kazama JJ, Narita I. High mortality rate of infectious diseases among dialysis patients: A comparison with the general population in Japan. Ther Apher Dial. 2012; 16(3): Wakasugi M, Kazama JJ, Narita I. Differences in the Local and National Prevalences of CKD Based on Annual Health Check Program Data. Clin Exp Nephrol. 2012; 16(5):

20 1. Otaki Y, Kouda R, Fujimura T, Nakatsue T, Wakasugi M, Murakami S, Kuroda T, Narita I, Nakano M, Gejyo F. Acute renal failure as a complication of acquired hemophilia due to autoantibody to factor VIII. Clin Exp Nephrol Oct ; 14. [Epub ahead of print] 木 戸 亮 (4 期 生 ) 10. Nishi H, Shibagaki Y, Kido R, Tamura S, Nangaku M, Sugawara Y, Fujita T. Chronic renal outcome after living donor liver transplantation. Clin Transplant [Epub ahead of print]. ( 査 読 あり;IF 1.667) 9. Kawarazaki H, Shibagaki Y, Kido R, Nakajima I, Fuchinoue S, Ando K, Fujita T, Fukagawa M, Teraoka S, Fukumoto S. Kidney transplantation restored uncoupled bone turnover in end-stage renal disease. Clin Nephrol. 2012; 78(1): ( 査 読 あり;IF 1.058) 8. Kawarazaki H, Shibagaki Y, Fukumoto S, Kido R, Ando K, Nakajima I, Fuchinoue S, Fujita T, Fukagawa M, Teraoka S. Natural history of mineral and bone disorders after living-donor kidney transplantation: a one-year prospective observational study. Ther Apher Dial. 2011; 15: ( 査 読 あり;IF 1.391) 7. Akizawa T, Kido R, Fukagawa M, Onishi Y, Yamaguchi T, Hasegawa T, Fukuhara S, Kurokawa K. Decreases in PTH in Japanese hemodialysis patients with secondary hyperparathyroidism: associations with changing practice patterns. Clin J Am Soc Nephrol. 2011; 6(9): ( 査 読 あり;IF 5.227) 6. Yazawa M, Kido R, Shibagaki Y, Yasuda T, Nakazawa R, Sasaki H, Sato Y, Chikaraishi T, Kimura K. Kidney function, albuminuria and cardiovascular risk factors in post-operative living kidney donors: a single-center, cross-sectional study. Clin Exp Nephrol. 2011; 15: ( 査 読 あり;IF 1.37) 5. Kawarazaki H, Shibagaki Y, Fukumoto S, Kido R, Nakajima I, Fuchinoue S, Fujita T, Fukagawa M, Teraoka S. The relative role of fibroblast growth factor 23 and parathyroid hormone in predicting future hypophosphatemia and hypercalcemia after living donor kidney transplantation: a 1-year prospective observational study. Nephrol Dial Transplant. 2011; 26: ( 査 読 あり;IF 3.396) 4. Nishi H, Shibagaki Y, Hirano K, Akahane M, Kido R, Nangaku M, Kaname S, Sasahira N, Isayama H, Tada M, Tsukamoto R, Ohtomo K, Omata M, Fujita T. Laboratory and imaging features of kidney involvement in autoimmune pancreatitis: incidence, correlation, and steroid therapy response. Clin Nephrol. 2010; 73: ( 査 読 あり;IF 1.058) 3. Kido R, Shibagaki Y, Iwadoh K, Nakajima I, Fuchinoue S, Fujita T, Teraoka S. Persistent glomerular hematuria in living kidney donors confers a risk of progressive kidney disease in donors after heminephrectomy. Am J Transplant. 2010; 10: ( 査 読 あり;IF 6.394) 2. Kido R, Shibagaki Y, Iwadoh K, Nakajima I, Fuchinoue S, Fujita T, Teraoka S. Very low but stable glomerular filtration rate after living kidney donation: is the concept of "chronic kidney disease" applicable to kidney donors? Clin Exp Nephrol. 2010; 14: ( 査 読 あり;IF 1.37) 1. Kido R, Shibagaki Y, Iwadoh K, Nakajima I, Fuchinoue S, Fujita T, Teraoka S. How do living kidney donors develop end-stage renal disease? Am J Transplant. 2009; 9: ( 査 読 あり;IF 6.394) 19

82 1. Yokoyama Y, Suzukamo Y, Hotta O, Yamazaki S, Kawaguchi T, Hasegawa T, Chiba S, Moriya T, Abe E, Sasaki S, Haga M, Fukuhara S. Dialysis Staff Enc

82 1. Yokoyama Y, Suzukamo Y, Hotta O, Yamazaki S, Kawaguchi T, Hasegawa T, Chiba S, Moriya T, Abe E, Sasaki S, Haga M, Fukuhara S. Dialysis Staff Enc 82 25 50 116 14 2010 1 31 1 82 1. Yokoyama Y, Suzukamo Y, Hotta O, Yamazaki S, Kawaguchi T, Hasegawa T, Chiba S, Moriya T, Abe E, Sasaki S, Haga M, Fukuhara S. Dialysis Staff Encouragement and fluid control

More information

研究成果報告書

研究成果報告書 21 4 25 peroxynitrite angiotensin II ETA MEK/ERK pathway endothelin-1 EDHF (EDHF) EDHF EDHF EDHF 2 [phosphodiesterase 3 (PDE3) cilostazol metformin thromboxane A2 ozagrel eicosapentaenoic acid (EPA) angiotensin

More information

1) University Group Diabetes Program: A study of hypoglycemic agents on vascular complica- in patients with adult-onset tions diabetes. I. Design, methods and baseline results. Diabetes 19 (suppl. 2):

More information

6) Suzuki S, Nakatomi Y, Sato H et al: Haemophilus bearing lymphocytes and increased polymeric IgA synthesis. Clin Exp Immunol 57: 101-106, 1984. 1) Berger J, Hinglais N: Les depots intercapillaires d'iga-igg.

More information

Table 1 Patients with various renal function * Ccr, Creatinine clearance ml/min per 1. 48 m2 ** C.V.D., Cerebral vascular disease ; C.R F., Chronic renal failure ; H.D., Hemoclialysis ; D., Dialyzer ;

More information

21-07_後藤論文.smd

21-07_後藤論文.smd 2015; 21: 5866 Yoichi Goto: Current status and future perspective of cardiac rehabilitation in Japan. J Jpn Coron Assoc 2015; 21: 5866 I 1 1 3 1 2 3 QOL 2 Fig. 1 1 196070 AMI AMI 1980 AMI CABG comprehensive

More information

Microsoft Word - 「黄砂とその健康影響について」小冊子180323版

Microsoft Word - 「黄砂とその健康影響について」小冊子180323版 ...1...1...1...2...4...4...4...6...7...7...7...7...8...8...9...9...10... 11... 11... 11... 11...12...12...13...16...18...20 1 1-1 1-2 1 1 km 24.5 m/s 10 50 m 1 1-3 μm 1-4 1-5 2 8 http://www.jma-net.go.jp/sat/himawari/obsimg/image_dust.html

More information

Juntendo Medical Journal

Juntendo Medical Journal Recent progress in nephrology Key words: rapid high elf icency dialysis, phosphate transport, plasma membrane Na+ transport, cytokine, extracellular matrix 5) Nagasawa M, Koide H, Ohsawa K, Hoshi

More information

Efficacy of Colestimide as a phosphate binder in patients on chronic hemodialysis Toshiyuki Date, Yoshiteru Kawashita, Nobuyoshi Satake Jin-ai-kai Dat

Efficacy of Colestimide as a phosphate binder in patients on chronic hemodialysis Toshiyuki Date, Yoshiteru Kawashita, Nobuyoshi Satake Jin-ai-kai Dat Efficacy of Colestimide as a phosphate binder in patients on chronic hemodialysis Toshiyuki Date, Yoshiteru Kawashita, Nobuyoshi Satake Jin-ai-kai Date Clinic In some patients on chronic hemodialysis,

More information

asymmetric dimethylarginine Table 1 CKD / 2 GFR 60 GFR(ml/min/1.73 m 2 )= age Cr Stage Definition GFR(ml/min/1.73

asymmetric dimethylarginine Table 1 CKD / 2 GFR 60 GFR(ml/min/1.73 m 2 )= age Cr Stage Definition GFR(ml/min/1.73 Online publication January 14, 2011 総 説 第 50 回総会シンポジウム 2 循環器内科系 : 内皮と脈管疾患 血管 - 腎連関と asymmetric dimethylarginine 1 2 1 要旨 : CKD: chronic kidney disease CKD Asymmeteric dimethylarginen ADMA ADMA ADMA ADMA

More information

Fig. 1 Chemical structure of DL-8280

Fig. 1 Chemical structure of DL-8280 Fig. 1 Chemical structure of DL-8280 Fig. 2 Susceptibility of cl in ical isolates to DL4280 Fig. 5 Susceptibility of clinical isolates to DL-8280 Fig. 3 Susceptibility of clinical isolates to DL-8280 Fig.

More information

36:378 第 38 回日本脳卒中学会講演シンポジウム 原著 36: , 要旨 TIA 2 t-pa Key words: stroke registry, stroke subtype, onset-visi

36:378 第 38 回日本脳卒中学会講演シンポジウム 原著 36: , 要旨 TIA 2 t-pa Key words: stroke registry, stroke subtype, onset-visi 36:378 第 38 回日本脳卒中学会講演シンポジウム 原著 36: 378 384, 2014 1 2 要旨 1999 2012 10 31 29 26 80 30 TIA 2 t-pa Key words: stroke registry, stroke subtype, onset-visit time, chronological change はじめに 4 12 23 27 1 Japan

More information

研究成果報告書

研究成果報告書 系 レニン 1. Ito D, Ito O, Mori N, Suda C, Hao K, Cao P, Muroya Y, Takashima K, Shimokawa H, Kohzuki M. Exercise training upregulates nitric oxide synthases in the kidney of rats with chronic heart failure.

More information

スライド 1

スライド 1 1 2006 msv 2 2011 3 CT 2011 10mSv 10 40mSv 4 2012 217mSv 5 (CT) 2012 50 60mSv 6 2012 510mSv BRCA25 310 10mSv3% BRCA60-280% 3 5m Sv 1m Sv 12% . http://www.rea.or.jp/ire/pdf/report4.pdf 1.10 20 SMR 1.00

More information

Treatment for Rheumatoid Arthritis in Elderly Patients to be Provided by Orthopedic Surgeons Satoshi ITO Division of Clinical Immunology, Advanced Bio

Treatment for Rheumatoid Arthritis in Elderly Patients to be Provided by Orthopedic Surgeons Satoshi ITO Division of Clinical Immunology, Advanced Bio Treatment for Rheumatoid Arthritis in Elderly Patients to be Provided by Orthopedic Surgeons Satoshi ITO Division of Clinical Immunology, Advanced Biomedical Applications, Graduate School of Comprehensive

More information

慢性膵炎

慢性膵炎 - - 121 , g CCK g g - kgkcal kgkcal - g,,, - G.I.Res ; 10 : - ; 13 : - ; 22 : - Meier RF, Beglinger C. Nutrition in pancreatic diseases. Best Pract Res Clin Gastroenterol ; 20 : - Pfutzer RH, Schneider

More information

CA CA19-9 CA19-9 CA CA CA19-9 ARCHITECT i 2000SR CLIA U/mL CA % CA CA

CA CA19-9 CA19-9 CA CA CA19-9 ARCHITECT i 2000SR CLIA U/mL CA % CA CA 原 著 30 22-29, 2015 CA19-9 CA19-9 CA19-9 2006 12013 6 CA19-9 32,508 37.0U/mL 790 2 CA19-9 320 CA19-9 ARCHITECT i 2000SRCLIA 0.0 37.0U/mL 8 4 1 2 18CA19-9 198.2 46.4 2,968 U/mL 5 3 2.5% CA19-9 2.5% CA19-9

More information

15K00827 研究成果報告書

15K00827 研究成果報告書 (TG) TG sterol regulatory element- binding protein (SREBP)-1c (Diabetes 53:560-569, 2004) SREBP-1c (1) SREBP-1c SREBP-1c liver X receptor (LXR)LXR O-Glc NAc (O-linked -N-acetyl glucosamine) (J Biol Chem

More information

教室業績2014

教室業績2014 MFICU MFICU : - : - : -,,, : - : -- - : - : - : - - - : - - - - : - : - : - : -, : - Takano Y, Furukawa S, Ohashi M, Michikata K, Sameshima H, Ikenoue T J Obstet Gynaecol Res, : -, CTG - CTG - : - Katsuragi

More information

8 The Bulletin of Meiji University of Integrative Medicine API II 61 ASO X 11 7 X-4 6 X m 5 X-2 4 X 3 9 X 11 7 API 0.84 ASO X 1 1 MR-angio

8 The Bulletin of Meiji University of Integrative Medicine API II 61 ASO X 11 7 X-4 6 X m 5 X-2 4 X 3 9 X 11 7 API 0.84 ASO X 1 1 MR-angio 7-14 2010 1 1 1 2 1 1 1 2 Fontaine II ASO61 3 API ASO ASO ASO API API KKKKKKKKKK ASO Fontaine II API Received April 14, 2009; Accepted July 16, 2009 I arteriosclerosis obliterans: ASO ASO 50 70 1,2 Fontaine

More information

教室業績2014

教室業績2014 p- p- p- p- : - N-N : - : - : - - : - : - : - : - Katakami H, Hashida S, Oki Y, Murakami O, Ikenoue T, Ono H, Matsukura S Clin Pediatr Endocrinol, suppl : -,. Ochiai H, Ikeda T, Mishima K, Yoshikawa T,

More information

124 IgA 3 3 IgA IgA 16 IgA H-Grade25 %25 % 50 % 50 % 75 %75 % g C-Grade 0.5 g egfr 60 ml min 1.73 m 2 C-Grade 0.5 g egfr 60 ml min

124 IgA 3 3 IgA IgA 16 IgA H-Grade25 %25 % 50 % 50 % 75 %75 % g C-Grade 0.5 g egfr 60 ml min 1.73 m 2 C-Grade 0.5 g egfr 60 ml min 2011 53 2123 135. IgA IgA 3 IgA 3 IgA IgA 1995 IgA 2002 IgA 2 IgA IgA IgA IgA 3 Clinical guides for immunoglobulin A IgA nephropathy in Japan, third version 124 IgA 3 3 IgA IgA 16 IgA 5 287 1 2 4 H-Grade25

More information

2001 2003 2005 2006 2007 2008

2001 2003 2005 2006 2007 2008 2001 2003 2005 2006 2007 2008 60 etc. http://nosmoke.hp.infoseek.co.jp/yuugaibussitu.htm http://nosmoke.hp.infoseek.co.jp/yuugaibussitu.htm 23.5% 2.8% 2.8% 3.4% 30.3% 9.9% 11.5% 15.8% AAN 65

More information

Cytokine-adsorbing hemofilter:バクスター セプザイリス(AN69ST膜hemofilter)

Cytokine-adsorbing hemofilter:バクスター セプザイリス(AN69ST膜hemofilter) Cytokine-adsorbing hemofilter AN69ST hemofilter Acute Care Kazuhiro MORIYAMA, Noriko ONOZUKA, Hidehito TSUNASHIMA 1. はじめに 1) CRRT AN69ST 2) sepxiris 2014 7 1 2 AN69ST 2. AN69 膜の開発経緯 1960 1969 著者連絡先 Acute

More information

<95DB8C9288E397C389C88A E696E6462>

<95DB8C9288E397C389C88A E696E6462> 2011 Vol.60 No.4 p.332 338 Usefulness of regional education program for dietary salt reduction: Self-monitoring of urinary salt excretion Kenichiro YASUTAKE[1] Kayoko SAWANO[1] Shoko YAMAGUCHI[1] Hiroko

More information

126mg/dL HbA1c 6.5 1, TG/HDL-C BMI Mann-Whitney U Logrank TG/HDL-C Cox SPSS Statistics ver22ibm EZR 5 ver2.1-2 TG/HDL-C TG/

126mg/dL HbA1c 6.5 1, TG/HDL-C BMI Mann-Whitney U Logrank TG/HDL-C Cox SPSS Statistics ver22ibm EZR 5 ver2.1-2 TG/HDL-C TG/ 原 著 31 462-467 2016 TG/HDL-C 10 TG/HDL-C TG/HDL-C 10 retrospective TG/HDL-Chomeostasis model assessment-insulin resistance HOMA-IR 10 TG/HDL-C TG/HDL-C HOMA-IR 75 2.6 1.4 10 2001 TG/HDL-C 2 TG/HDL-C TG/HDL-C

More information

CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study

CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study CHEMOTHERAPY JUNE 1993 Table 1. Background of patients in pharmacokinetic study VOL. 41 S 1 Table 2. Levels (Đg/ml or Đg/g) of S-1006 in serum, bile, and tissue (gallbladder) after oral administration

More information

本文.indd

本文.indd CQ ACC/AHA PECO PatientExposure Comparison OutcomePECO low-density lipoprotein cholesterol LDL C cholesterol cholesterol intensive OR agressive CQ target LDL C PubMed Systematic Reviews Clinical Study

More information

C/NC : committed/noncommitted

C/NC : committed/noncommitted C/NC : committed/noncommitted 110 time post-icd implant 1) The Cardiac Arrhythmia Suppression Trial (CAST) Investigators Preliminary report : Effect of encainaide and flecainide on mortality in a

More information

A Nutritional Study of Anemia in Pregnancy Hematologic Characteristics in Pregnancy (Part 1) Keizo Shiraki, Fumiko Hisaoka Department of Nutrition, Sc

A Nutritional Study of Anemia in Pregnancy Hematologic Characteristics in Pregnancy (Part 1) Keizo Shiraki, Fumiko Hisaoka Department of Nutrition, Sc A Nutritional Study of Anemia in Pregnancy Hematologic Characteristics in Pregnancy (Part 1) Keizo Shiraki, Fumiko Hisaoka Department of Nutrition, School of Medicine, Tokushima University, Tokushima Fetal

More information

Validation of a Food Frequency Questionnaire Based on Food Groups for Estimating Individual Nutrient Intake Keiko Takahashi *', Yukio Yoshimura *', Ta

Validation of a Food Frequency Questionnaire Based on Food Groups for Estimating Individual Nutrient Intake Keiko Takahashi *', Yukio Yoshimura *', Ta Validation of a Food Frequency Questionnaire Based on Food Groups for Estimating Individual Nutrient Intake Keiko Takahashi *', Yukio Yoshimura *', Tae Kaimoto *', Daisuke Kunii *', Tatsushi Komatsu *2

More information

body size no effect mechanical stress GH-IGF1 system + no effect? collagen production of fibroblasts + receptor + + Ia, Ib, II aldosterone renin angiotensin system Mechanical and Endocrinological

More information

1315 (15)

1315 (15) (14) 1315 (15) 1316 (16) 1317 (17) 1318 (18) 1319 (19) 1320 (20) 1321 (21) 1322 quinidine, disopyramide, and procainamide in isolated atrial myocytes : Mediation by 2) Inoue H, et al: Effects of pentisomide

More information

Noninvasive estimation of pulmonary capillary wedge pressure and cardiac output by the analysis of pulmonary venous flow velocity patterns in patients

Noninvasive estimation of pulmonary capillary wedge pressure and cardiac output by the analysis of pulmonary venous flow velocity patterns in patients Noninvasive estimation of pulmonary capillary wedge pressure and cardiac output by the analysis of pulmonary venous flow velocity patterns in patients with acute congestive heart failure Jung-Myung Lee,

More information

988 CHEMOTHERAPY NOV. 1971

988 CHEMOTHERAPY NOV. 1971 988 CHEMOTHERAPY NOV. 1971 VOL. 19 NO. 8 CHEMOTHERAPY 989 Effect of medium-ph and inoculum size on activity of SB-PC heart infusion agar, mcg/ml Sensitivity distribution of Staphylococci to SB-PC in surgical

More information

Clinical Study of Effect of Intrathecal Use of Alpha-tocopherol on Chronic Vasospasm Hirotoshi Sano, Motoi Shoda, Youko Kato, Kazuhiro Katada, Youichi

Clinical Study of Effect of Intrathecal Use of Alpha-tocopherol on Chronic Vasospasm Hirotoshi Sano, Motoi Shoda, Youko Kato, Kazuhiro Katada, Youichi Clinical Study of Effect of Intrathecal Use of Alpha-tocopherol on Chronic Vasospasm Hirotoshi Sano, Motoi Shoda, Youko Kato, Kazuhiro Katada, Youichi Shinomiya and Tetsuo Kanno Department of Neurosurgery,

More information

Title 歯性病巣の関連する皮膚疾患におけるビオチンの効用 Author(s) 高橋, 愼一 ; 川島, 淳子 ; 森本, 光明 ; 山根, 源之 Journal, (): - URL Right Posted at the Inst

Title 歯性病巣の関連する皮膚疾患におけるビオチンの効用 Author(s) 高橋, 愼一 ; 川島, 淳子 ; 森本, 光明 ; 山根, 源之 Journal, (): - URL   Right Posted at the Inst Title 歯性病巣の関連する皮膚疾患におけるビオチンの効用 Author(s) 高橋, 愼一 ; 川島, 淳子 ; 森本, 光明 ; 山根, 源之 Journal, (): - URL http://hdl.handle.net/10130/526 Right Posted at the Institutional Resources for Unique Colle Available from

More information

1 2 D- D- 1206 D- D- -2003 120 /2004 D-FDA GRAS D D- 3 5 5 D- 75 10g/kg 14 40 20 D-101520 90 1520 20%101520 1520 D- 5(D- 2300-6700mg//) () 2024 615 D- 41220g/kg/ 1220g/kg/ 20g/kg/ 1220g/kg/ () 50 D- 10%

More information

研究成果報告書

研究成果報告書 X-SCID T NK Omenn T T 2007 2008 0menn T 1. 研究開始当初の背景 T T T T reversion T T 2. 研究の目的 RAG1/RAG2 Artemis T TCR T TCR 3. 研究の方法 RAG1/RAG2 μ μ μ μ μ μμ μμ μ 解析ダイアグラム 3-D display による TCR 多様性の評価 4. 研究成果 TCR T

More information

Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST

Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST Key words : Adverse reactions, Egg allergy, IgG antibody, Mills allergy, FAST 13) Danaeus, A., Johansson, S. G. O., Foucard, T. & Ohman, S.: Clinical and immunogical aspects of food allergy in childhood.

More information

研究成果報告書(基金分)

研究成果報告書(基金分) GCP(Golgi cytoplasmic protein) coiled-coil golgin GCP golgin golgin golgin golgin p115 golgin-84 COG 1,6 G, SNAREs, ER- p115 BBRC 2005,6 golgin giantin, golgin-84, CASP, p115 COPI golgin G SNAREs golgin-84

More information

日本化学療法学会雑誌第51巻第2号

日本化学療法学会雑誌第51巻第2号 piperacillin piperacillin PIPC. g Cmax CL PIPC CL CLR CLNR CL PIPC g g Cmax PIPC Key words: piperacillin Piperacillin PIPC PIPC g g PIPC Cmax g g ml g g ml g g ml T T T PIPC g g T Ccr ml min AUCCmax PIPC

More information

32 1 BRONJ BRONJ II BRONJ BRONJ 4 BP BRONJ 6 1 III BP BRONJ

32 1 BRONJ BRONJ II BRONJ BRONJ 4 BP BRONJ 6 1 III BP BRONJ 29 1 31 40 2014 31 Bisphosphonate related osteonecrosis of jaw; BRONJ 2008 4 2012 3 36 98 8 11 19 BRONJ 0 13 2 5 3 1 1 0 BP 4 15 10 5 α-streptococcus 0 BRONJ BRONJ BP I Paget 1 409-3898 1110 2014 1 27

More information

2

2 2 3 4 5 6 7 8 9 1 2 3 4 5 10 11 12 1 2 1 2 1 2 13 14 3 17 15 1 2 3 D Usefulness of Tc-99m MIBI SPECT in predicting multidrug resistance gene expression level in non-small cell lung cancer a preliminary

More information

1_2.eps

1_2.eps 第32回 日本頭頸部癌学会ランチョンセミナー6 Pre-Meeting Abstract FDG-PET の頭頸部癌における臨床的有用性 司会 長 放射線治療センター長 講演 1 耳鼻咽喉科 部長 講演 2 PETセンター長 岡村 光英 先生 日時 2008年6月13日 金 12:00 13:00 会場 ハイアットリージェンシー東京 共催 第32回 日本頭頸部癌学会 日本メジフィジックス株式会社 136-0075

More information

VOL.42 S-1

VOL.42 S-1 CHEMOTHERAPY APR. 1994 VOL.42 S-1 CHEMOTHERAPY APR. 1994 Table 1. Criteria for evaluation of clinical efficacy by the Japanese Society of Oral and Maxillo-Facial Surgeons Grades of symptoms and numerical

More information

スライド 1

スライド 1 ISEM WEST CHAPTER 2015 (The 3rd Meeting, 26 June 2015, Kyoto) 講義 : マイクロサージャリー : 臓器の壁を越えてーラット膵臓移植モデルから得られることー 腸管ドレナージは 小腸吻合技術に 膵腎同時移植は 尿管吻合技術に 実習 : ルーペから顕微鏡へー直径 2mm の血管に挑戦ー Eiji Kobayashi, MD,PhD Department

More information

v

v v CONTENTS 1 2 7 2 14 COLUMN 15 RAGEAGEs 21 COLUMN 22 26 COLUMN NADPH 28 32 COLUMN GLP1 36 39 COLUMN AGEs 44 46 54 COLUMN GWAS 55 59 3 66 COLUMN 69 COLUMN 1 2 71 vi 4 78 84 89 COLUMN GFR decliner 92 94

More information

VOL.35 S-2 CHEMOTHERAPY Table 1 Sex and age distribution Table 2 Applications of treatment with carumonam Table 3 Concentration of carumonam in human

VOL.35 S-2 CHEMOTHERAPY Table 1 Sex and age distribution Table 2 Applications of treatment with carumonam Table 3 Concentration of carumonam in human CHEMOTHERAPY Fig. 1 Chemical structure of carumonam Disodium(+)-(Z)-CCE1-(2-amino-4-thiazoly1)-2-[[(2S, -(carbamoyloxymethyl)-4-oxo-1-sulfonato-3-azetidinyll -2-oxoethylidene] amino] oxy] acetate 3S)-2

More information

268 LSG 図 Lee ABCD 表 1 4 Age BMI C Duration Still DiaRem 表 1 4 HbA1c Ⅱ 対象と方法 1 17 LSG 6 3 Excess Weight Loss EWL BMI 25 kg/m 2 Hb

268 LSG 図 Lee ABCD 表 1 4 Age BMI C Duration Still DiaRem 表 1 4 HbA1c Ⅱ 対象と方法 1 17 LSG 6 3 Excess Weight Loss EWL BMI 25 kg/m 2 Hb 52 5 18 1 267 原著 ( 臨床研究 ) LSG ABCD DiaRem LSG 3 93.1 1 7.8 CR37.5 PR33.3 1 ABCD 5 DiaRem 12 LSG ABCD DiaRem LSG 腹腔鏡下スリーブ状胃切除術,ABCD スコア,DiaRem スコア Ⅰ はじめに Bariatric Surgery 2 1 metabolic surgery 2 ABCD 2

More information

_’£”R‡Ù‡©

_’£”R‡Ù‡© 29 31 38 2008 31 1) 2) 2) 3) 2) 1) 2008 302008 12 Activities of Daily Living ADL ADL 42 ADL ADL 1990 QOL Quality of Life QOL 1 QOL // 2 Activity of Daily Living ADL Performance Status PS ADL 3 1) 2) 3)

More information

Endocrinological and statistical analysis of ovarian function in hysterectomized patients Masaya HAYAFUJI, Kazuaki KATAYAMA and Matsuto MOCHIZUKI Depa

Endocrinological and statistical analysis of ovarian function in hysterectomized patients Masaya HAYAFUJI, Kazuaki KATAYAMA and Matsuto MOCHIZUKI Depa Endocrinological and statistical analysis of ovarian function in hysterectomized patients Masaya HAYAFUJI, Kazuaki KATAYAMA and Matsuto MOCHIZUKI Department of Obstetrics and Gynecology, Kobe University

More information

Background : There have not been any informations available of whether diuretics may enhance renoprotective effects of ACEI and ARB. Methods Post-hoc analysis of the results of COOPERATE trial, asking

More information

CHEMOTHERAPY FEB Table 1. Activity of cefpirome and others against clinical isolates

CHEMOTHERAPY FEB Table 1. Activity of cefpirome and others against clinical isolates VOL.39 S-1 CHEMOTHERAPY FEB. 1981 Table 1. Activity of cefpirome and others against clinical isolates VOL.39 S-1 CHEMOTHERAPY FEB. 1991 72 M, 55.5 kg 66 F, 53 kg Chronic bronchitis Bronchopneumonia Peak

More information

教室業績2014

教室業績2014 Campylobactor Fetus Population-based study Campylobacter fetus : : - : - : - : - : - NICU : - : - : - : - : - : - : - : - : : - Yamauchi N, Saemshima H, Fukushima K, Nagai K, Ikenoue T Journal of Gynecologic

More information

untitled

untitled 5 K 5 3 HP http://www.mhlw.go.jp/bunya/shakaihosho/iryouseido01/taikou03.html 2004 1 2 1 http://www.dm-net.co.jp/calendar/2007/06/005835.php 6 85cm 100cm 2 90cm 2 TG 150mg/dl HDLHDL-C 40mg/dl 130mmHg 85mmHg

More information

Table 1. Antibacterial activitiy of grepafloxacin and other antibiotics against clinical isolates

Table 1. Antibacterial activitiy of grepafloxacin and other antibiotics against clinical isolates Table 1. Antibacterial activitiy of grepafloxacin and other antibiotics against clinical isolates Table 2-1. Summary of patients treated with grepafloxacin for respiratory infection 1) Out: outpatient,

More information

26 1 : Self - reported Practices of Cancer Pain Management among Nurses in Tohoku University Hospital Hideyuki Hira

26 1 : Self - reported Practices of Cancer Pain Management among Nurses in Tohoku University Hospital Hideyuki Hira 26 1 : 35 45 2017 1 2 2 2 2 2 2 2 2 1 1 2 Self - reported Practices of Cancer Pain Management among Nurses in Tohoku University Hospital Hideyuki Hirayama 1, Yoko Nakajo 2, Akemi Saito 2, Rie Hatakeyama

More information

-1 [6] (malnutrition) (inflammation) 10~20 [11] (atherosclerosis) Malnutrition-Inflammation- Atherosclerosis syndrome (MIA syndrome) MIA (endothelium)

-1 [6] (malnutrition) (inflammation) 10~20 [11] (atherosclerosis) Malnutrition-Inflammation- Atherosclerosis syndrome (MIA syndrome) MIA (endothelium) 1993 Owen WF Jr New England Journal of Medicine (albumin) [1] 40 70% [2-4] (1) (2) (3) [5] ( 1 ) (2) (3) (4) 1931 Lyon et al [6] [7-10] (1) (2) (3) (4) (5) leptin -1 (insulin-like growth factor-1) [6]

More information

Table 1. Numbers of Cancerous Pleurisy Cases According to Primary Site Table 2. Histological Type of Lung Carcinoma with Cancerous Pleurisy at Autopsy

Table 1. Numbers of Cancerous Pleurisy Cases According to Primary Site Table 2. Histological Type of Lung Carcinoma with Cancerous Pleurisy at Autopsy Clinicopathological Studies on Cancerous Pleurisy, with Emphasis on Extra-Pulmonary Malignancy Table 1. Numbers of Cancerous Pleurisy Cases According to Primary Site Table 2. Histological Type of Lung

More information

1272 CHEMOTHERAPY MAR. 1975

1272 CHEMOTHERAPY MAR. 1975 1272 CHEMOTHERAPY MAR. 1975 VOL. 23 NO. 3 CHEMOTHERAPY 1273 Fig. 2 Minimal inhibitory concentration of aminoglycosides against 50 strains of Klebsiella Fig. 1 Minimal inhibitory concentration of aminoglycosides

More information

coccus aureus Corynebacterium sp, Haemophilus parainfluenzae Klebsiella pneumoniae Pseudornonas aeruginosa Pseudomonas sp., Xanthomonas maltophilia, F

coccus aureus Corynebacterium sp, Haemophilus parainfluenzae Klebsiella pneumoniae Pseudornonas aeruginosa Pseudomonas sp., Xanthomonas maltophilia, F VOL.43 S-1 coccus aureus Corynebacterium sp, Haemophilus parainfluenzae Klebsiella pneumoniae Pseudornonas aeruginosa Pseudomonas sp., Xanthomonas maltophilia, Flavobacter- Table 1. Concentration of grepafloxacin

More information

Effect of Supplementation of Sulfur-Containing Amino Acids to a Low-Soy Protein Diet Containing Cholesterol on Plasma Cholesterol Levels in Rats Tokik

Effect of Supplementation of Sulfur-Containing Amino Acids to a Low-Soy Protein Diet Containing Cholesterol on Plasma Cholesterol Levels in Rats Tokik Effect of Supplementation of Sulfur-Containing Amino Acids to a Low-Soy Protein Diet Containing Cholesterol on Plasma Cholesterol Levels in Rats Tokiko MIZUNO, Hiroko ABE, Ryuji HIRANO and Koji YAMADA

More information

2 10 The Bulletin of Meiji University of Integrative Medicine 1,2 II 1 Web PubMed elbow pain baseball elbow little leaguer s elbow acupun

2 10 The Bulletin of Meiji University of Integrative Medicine 1,2 II 1 Web PubMed elbow pain baseball elbow little leaguer s elbow acupun 10 1-14 2014 1 2 3 4 2 1 2 3 4 Web PubMed elbow pain baseball elbow little leaguer s elbow acupuncture electric acupuncture 2003 2012 10 39 32 Web PubMed Key words growth stage elbow pain baseball elbow

More information

CHEMOTHERAPY APR Fig. 2 The inactivation of aminoglycoside antibiotics by PC-904 Fig. 3 Serum concentration of PC-904 (1) Fig. 4 Urinary recover

CHEMOTHERAPY APR Fig. 2 The inactivation of aminoglycoside antibiotics by PC-904 Fig. 3 Serum concentration of PC-904 (1) Fig. 4 Urinary recover VOL.26 S-2 CHEMOTHERAPY Gentamicin (GM), Dibekacin (DKB), Tobramycin Fig. 1 Protein concentration and protein binding rate Table 2 Protein binding rate of PC-904 in serum of healthy adults, and patients

More information

CHEMOTHERAPY FEB Table 1 Background of volunteers

CHEMOTHERAPY FEB Table 1 Background of volunteers CHEMOTHERAPY FEB. 1985 Table 1 Background of volunteers Table 3 Reproducibility of saisomicln In the EIA and the RIA Fig.1 Comparison of the EIA with the RIA or bioassay of sisomicin Table 4 Blood levels

More information

A study on thyroid function in patients on chronic dialysis Masahumi Kikkawa, Issei Tanaka, Naoki Haruta, Takao Hinoi, Tamaki Nakatani, Kazuaki Miyamo

A study on thyroid function in patients on chronic dialysis Masahumi Kikkawa, Issei Tanaka, Naoki Haruta, Takao Hinoi, Tamaki Nakatani, Kazuaki Miyamo A study on thyroid function in patients on chronic dialysis Masahumi Kikkawa, Issei Tanaka, Naoki Haruta, Takao Hinoi, Tamaki Nakatani, Kazuaki Miyamoto Artifical Kidney Center, Hiroshima Prefectural Hiroshima

More information

™…

™… Review The Secret to Healthy Long Life Decrease in Oxidative and Mental Stress My motto is Health is not all. But nothing can be done without health. Health is the most important requisite for all human

More information

1) Delbet P: Retrocissement du choledoque. Cholecysto-duodenostomie. Bull Mem Soc Nat Chir 50: 1144-1146, 1924 2) Wiesner RH, LaRusso NF: Clinicopathologic Features of the Syndrome of Primary Sclerosing

More information

Nutrition and hemodialysis status of long-surviving hemodialysis patients Hiroshi Watanabe*1, Yoshiko Okada*2, Masahiro Mori*1, Takashi*2, Hidehiro Ta

Nutrition and hemodialysis status of long-surviving hemodialysis patients Hiroshi Watanabe*1, Yoshiko Okada*2, Masahiro Mori*1, Takashi*2, Hidehiro Ta Nutrition and hemodialysis status of long-surviving hemodialysis patients Hiroshi Watanabe*1, Yoshiko Okada*2, Masahiro Mori*1, Takashi*2, Hidehiro Tanji*2, Naohisa Ibuki*2, Yorimitsu Tatsukawa*2, Yoshihiko

More information

第61巻5・6号(12月号)/特集1頁目(本刷)

第61巻5・6号(12月号)/特集1頁目(本刷) Special Issue 1Sudden cardiac death symposium in Tokushima Special Issue 2How to do for your health? Reviews Original Epidemiologic problems of sudden death of school children in Tokushima Prefecture

More information

Key words : 7432-S, Oral cephem, Urinary tract infection Fig. 1. Chemical structure of 7432-S.

Key words : 7432-S, Oral cephem, Urinary tract infection Fig. 1. Chemical structure of 7432-S. Key words : 7432-S, Oral cephem, Urinary tract infection Fig. 1. Chemical structure of 7432-S. Table 1. Clinical summary of acute uncomplicated cystitis patients treated with 7432-S UTI : Criteria by the

More information

女子短大生に対する栄養マネジメント教育とその評価

女子短大生に対する栄養マネジメント教育とその評価 10 11 12 http://www.center.ibk.ed.jp/contents/kenkyuu /houkoku/data/030s/sport1.htm http://www.mhlw.go.jp/bunya/kenkou/eiy ou/dl/h24-houkoku.pdf http://www.mhlw.go.jp/bunya/kenkou/dl/ kenkounippon21_02.pdf

More information

5) Kawada T, Hagihara K, Iwai K (1986) Effects of capsaicin on lipid metabolism in rats fed a high fat diet. J Nutr 116 : 1272-8. 6) Kawada T, Watanabe T, Takaishi T, Tanaka T, Iwai K (1986) Capsaicin-induced

More information

Effects of Diet Class on Overweight Middle-aged Women Analysis of Nutritional Intake Pattern YAMAGUCHI Shizue*, MATSUMOTO Tomoko**, MIMURA Kan-ichi***, ASAI Hitoshi****, OKUDA Toyoko***** * O saka Shin-ai

More information

Fig. 1 Trends of TB incidence rates for all forms and smear-positive pulmonary TB in Kawasaki City and Japan. Incidence=newly notified cases of all fo

Fig. 1 Trends of TB incidence rates for all forms and smear-positive pulmonary TB in Kawasaki City and Japan. Incidence=newly notified cases of all fo Kekkaku Vol. 79, No. 1: 17-24, 2004 17 (Received 21 Aug. 2003/Accepted 18 Nov. 2003) Fig. 1 Trends of TB incidence rates for all forms and smear-positive pulmonary TB in Kawasaki City and Japan. Incidence=newly

More information

Special IssueDiagnoses and therapeutic agents for age-related diseases Reviews Original Case reports β Medicinal drugs affecting on clinical laboratory blood test results and adverse effects of them

More information

1) Garner J. S.: The Hospital Infection Control Practices Advisory Committee, CDC, Guidelines for Isolation Precautions in Hospitals, 1996. http://wonder.cdc.gov/wonder/prevguid/ p0000419/p0000419.asp.

More information

日本消化器外科学会雑誌第29巻第9号

日本消化器外科学会雑誌第29巻第9号 Table 1 Oligonucleotide primers used for RT-PCR and internal probes used for Southern blot hybridization Cytokine Primer Sequence (5'-3') 5' 3' Internal probe s' 3' Internal probe 5' 3' Internal probe

More information

VOL. 36 S-3 CHEMOTHERAPY 437

VOL. 36 S-3 CHEMOTHERAPY 437 VOL. 36 S-3 CHEMOTHERAPY 437 438 CHEMOTHERAPY JULY 1988 Fig. 1 Contractile response of gastrointestinal tract to intravenous administration of saline and EM in interdigestive state in dogs (a) : Saline,

More information

第56巻6号/投稿規定・目次・表2・奥付・背

第56巻6号/投稿規定・目次・表2・奥付・背 Feature articlesthe Front of Stroke Management Originals α Imaging protocol for apoplexy of acute phase Masafumi Harada, Kazuhide Yoneda, Naomi Morita, Mayumi Takeuchi, Sonoka Hisaoka, Toshiko Okada,

More information

m «É w «Ÿ ÉÉ É É ÉÉ É É

m «É w «Ÿ ÉÉ É É ÉÉ É É É ÉÉÉÉ ÉÉ Zacc m «É w «Ÿ ÉÉ É É ÉÉ É É É É É É É É É ÉÉ É Uninephrectomy induces Progressive Glomerulosclerosis and Apoptosis in Anti Thy Glomerulonephritis VEGF Gene Expression is Correlated with Glomerular

More information

untitled

untitled Vol.4(2008) pp.41-52 1 1 2 3 1 1 1 2 3 19 12 20 Preliminary Studies of Robot Assisted Rehabilitation Using Commercially Available Entertainment Robots Toshihiro TETSUI 1 Eiichi OHKUBO 1 Noriko KATO 2 Shin

More information

STUDIES ON THE RELATION BETWEEN LATE DUMPING SYNDROME AND GLUCAGON RESPONCES TO GLUCOSE Taisuke MATSUI The First Department of Surgery, Nara Medical U

STUDIES ON THE RELATION BETWEEN LATE DUMPING SYNDROME AND GLUCAGON RESPONCES TO GLUCOSE Taisuke MATSUI The First Department of Surgery, Nara Medical U STUDIES ON THE RELATION BETWEEN LATE DUMPING SYNDROME AND GLUCAGON RESPONCES TO GLUCOSE Taisuke MATSUI The First Department of Surgery, Nara Medical University, Kashihara (Director: Prof. H. Nakano) This

More information

特殊病態下感染症における抗菌薬治験の手引き作成委員会報告書(案)

特殊病態下感染症における抗菌薬治験の手引き作成委員会報告書(案) VOL.51 NO.6 JUNE 2003 JUNE 2003 9) Niederman MS et al: Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy and prevention.

More information

Special IssueOncology Nutrition Reviews Proceeding DNA β Nutrition and physical activity and the prevention of cancer Yutaka Taketani Department of Clinical Nutrition, Institute of Health Biosciences,

More information

JAGES 1 http://www.mlit.go.jp/common/000135841.pdf http://www.mhlw.go.jp/file/04-houdouhappyou-12004000-shakaiengokyoku-shakai-fukushikibanka/270624houdou.pdf_2.pdf 21 59 10 vs 9 8,500 8,000 7,500 7,000

More information

Influences of mortality from main causes of death on life expectancy. \ An observation for the past 25 years, 1950-1975, in Japan \ Takao SHIGEMATSU* and Zenji NANJO** With the Keyfitz-Nanjo method an

More information

1) Steinbrocker, O.: The shoulder-hand syndrome in reflex dystrophy of the upper ex- tremity, Ann. Intern. Med., 29: 22, 1948. 5) Greenfield, A. D. M., Whitney, R. J. and Mowbray, J. F.: Methods for the

More information

"G um exp." in the table means before the gum chewing experiment, and "Cont exp." in the table means Table 1. Rest values of heart rate (HR), coefficient of variation in RR (CVRR), wave height of plethysmogram

More information

Fig. 1. Structures of NM394, NAD-358 and NAD-245 Fig. 2. Typical HPLC chromatograms of NM394 in human plasma by organic solvent extraction method (a): Blank plasma (b): Plasma spiked with NM394 and internal

More information

Key words : candidemia, endotoxin, D-arabinitol, Candida antigen, serological examination

Key words : candidemia, endotoxin, D-arabinitol, Candida antigen, serological examination Key words : candidemia, endotoxin, D-arabinitol, Candida antigen, serological examination Fig. 1 The value of fungal index and D- arabinitol/creatinine. Fungal index was mesured by Endotoxin D and Endospecy

More information

研究成果報告書(基金分)

研究成果報告書(基金分) (1) 種類 程度 肥満細胞数の測定と組織でのサ RT-PCR FACS () (1) NMU-/- IgE NMU IgE -/-NMU -/-B IgE NMU -/-B6 IgE NMU NMU CTLMC BMMC IgE NMU CTLMC 13 1. Hayakawa J, Mizukawa Y, Kurata M, Shiohara T: A syringotropic variant

More information

<95DB8C9288E397C389C88A E696E6462>

<95DB8C9288E397C389C88A E696E6462> 2011 Vol.60 No.2 p.138 147 Performance of the Japanese long-term care benefit: An International comparison based on OECD health data Mie MORIKAWA[1] Takako TSUTSUI[2] [1]National Institute of Public Health,

More information

2 The Bulletin of Meiji University of Integrative Medicine 3, Yamashita 10 11

2 The Bulletin of Meiji University of Integrative Medicine 3, Yamashita 10 11 1-122013 1 2 1 2 20 2,000 2009 12 1 2 1,362 68.1 2009 1 1 9.5 1 2.2 3.6 0.82.9 1.0 0.2 2 4 3 1 2 4 3 Key words acupuncture and moxibustion Treatment with acupuncture, moxibustion and Anma-Massage-Shiatsu

More information

Jan THE JAPANESE JOURNAL OF ANTIBIOTICS XL-1 Table 1. Outline of administering doses, routes and sampling times *: 4 ml/hr/kg Bacillus subtilis

Jan THE JAPANESE JOURNAL OF ANTIBIOTICS XL-1 Table 1. Outline of administering doses, routes and sampling times *: 4 ml/hr/kg Bacillus subtilis THE JAPANESE JOURNAL OF ANTIBIOTICS XL-1 Jan. 1987 Jan. 1987 THE JAPANESE JOURNAL OF ANTIBIOTICS XL-1 Table 1. Outline of administering doses, routes and sampling times *: 4 ml/hr/kg Bacillus subtilis

More information

Changes in Electrodermal Activity Associated with Candies and Chewing Gum Chewing Satoshi Beppu, Takeshi Morita*, Susumu Igarashi **, Kanichi Seto* an

Changes in Electrodermal Activity Associated with Candies and Chewing Gum Chewing Satoshi Beppu, Takeshi Morita*, Susumu Igarashi **, Kanichi Seto* an Changes in Electrodermal Activity Associated with Candies and Chewing Gum Chewing Satoshi Beppu, Takeshi Morita*, Susumu Igarashi **, Kanichi Seto* and Yosihiro Amemiya Abstract: This study was designed

More information

<30388DE288E42E696E6464>

<30388DE288E42E696E6464> Doshisha Journal of Health & Sports Science, 1, 53-60, 2009 53 1 Effects of Step Exercise in Healthy Older People Tomoaki Sakai 1 The purpose of this study was to determine the effect of step exercise

More information

Fig. 1 Photography of exercise test by Arm Crank Ergometer. Fig. 2 Photography of exercise test by chair with caster. Arm Crank Ergometer Wheelchair T

Fig. 1 Photography of exercise test by Arm Crank Ergometer. Fig. 2 Photography of exercise test by chair with caster. Arm Crank Ergometer Wheelchair T Fig. 1 Photography of exercise test by Arm Crank Ergometer. Fig. 2 Photography of exercise test by chair with caster. Arm Crank Ergometer Wheelchair Treadmill Arm Crank Ergometer Arm Crank Ergometer Arm

More information

untitled

untitled 27 4 1 50 151 80.8 1037.9 66.2 52.5 26 13 4 17 1 8 10 3 1 8.4 2741 13 68.4 4 21.1 2 10.5 3 2 5 25 1 8 40 4 20 3 15 27 4 1 48 151 151 501 A B 26 89.5 4133.8. 62.2 1 12 25 1 2 1 1 2 2 25 4.5 2741 32 74.4%

More information